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Summary 
I studied three biological problems in my dissertation research. The problems involved 
flow of information into the cells from outside, the regulation of information flow by the 
ribosomes in protein synthesis, and the disruption of information flow due to 
microsatellite repeat expansions leading to a human disease myotonic dystrophy. In the 
first study, I built a conceptual basis for interpreting and understanding the cellular 
responses to multiple concurrent stimuli. A gene represents the inherent information of 
the cells while a stimulus represents the information outside their boundary. Since a 
gene and a stimulus are both packets of information, they can be considered 
analogues. Therefore, the concepts of gene interactions can be applied to the study of 
modulation of cellular processes by stimuli. This assumption allowed me to define the 
concepts of environmental interactions and environmental epistasis in terms of gene 
interactions and genetic epistasis. I used proteomic and transcriptomic changes in 
Saccharomyces cerevisiae to test the conceptual framework. In the second study, I 
designed and performed experiments to test the ribosome filter hypothesis. The 
ribosome filter hypothesis says that the amount of information flow from a transcript to a 
protein is regulated by the compositions of the subpopulations of ribosomes in a cell. 
The composition of a ribosome determines its interactions with the mRNA and 
accessory factors, which in turn determine the efficiency of translation of a transcript. 
Therefore, to efficiently translate the proteome required for growing in one 
environmental condition would require a specific complement of ribosomes with different 
compositions. The required complement of ribosomes will be different for a cell growing 
in a different environmental condition. A difference in the protein composition of 
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ribosomes from cells growing in two different conditions would be evidence supporting 
the ribosome filter hypothesis. It would allow identification of candidate ribosomal 
proteins, or their post-translation modifications that regulate information flow from 
specific transcripts. I used growth of S. cerevisiae with fermentable carbon source, 
glucose, and non-fermentable carbon source, glycerol, as two conditions. I used iTRAQ 
labeling based quantitative proteomics as well as, in collaboration with the Joachim 
Frank lab, cryo-electron microscopy to measure the changes in protein composition of 
ribosomes. I used yeast genetics and polysome profiling to measure the effect of loss of 
function of a candidate ribosomal protein, Rpl8a or Rpl8b, on translation. In the third 
project, I studied the changes introduced in the skeletal muscle proteome of myotonic 
dystrophy patients, both type 1 and 2, due to the disruption of information flow by 
microsatellite repeat expansions in the non-coding regions of mRNA transcripts. I used 
iTRAQ labeling based quantitative proteomics analysis to quantitate the changes in the 
skeletal muscle proteome of DM patients compared to healthy volunteers. I identified 
differentially present proteins and used pathway analysis to understand their role in the 
pathogenesis. I have identified a number of candidate proteins that are interesting 
targets for more in depth genetic and biochemical studies including a ribosomal protein 
RPL13A, previously implicated in regulating information flow by translational inhibition of 
transcripts containing the GAIT sequence motif. In summary, I have studied three 
different ways the information content of cells and tissues are affected. 
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Chapter I 
Introduction 
An organism alters its biochemical state in response to the changes in its environment 
or the stage in its life cycle. One way it can alter its biochemical state is by regulating its 
cellular proteome. Regulation of the cellular proteome is essential for continued survival 
of an organism. In my research, I studied three facets of regulation of cellular proteomes 
that I will describe in the subsequent chapters. This introduction has been divided into 
three parts to reflect the three projects described in my thesis. In the first part, I will 
present experimental evidence and model the cellular responses to multiple concurrent 
changes in the environmental conditions. I will describe a conceptual framework that 
helps understand the biological effects of the concurrent stimuli using changes in the 
cellular proteome and transcriptome of Saccharomyces cerevisiae. In the second 
project, I will present experimental evidence and discuss the role of ribosome as a 
regulatory element in translational control of the cellular proteome in S. cerevisiae. In 
the third project, I will dissect the misregulation of the human skeletal muscle proteome 
due to the expansion of microsatellite repeat elements in the human genome that leads 
to a human disease myotonic dystrophy. 
Regulation of the proteome by environmental stimuli. 
The interaction of an organism with its environment determines its internal 
biochemical state. In turn, the organism modifies the biochemical state of its 
environment by secretion of biomolecules or dissipation of chemical energy. The 
process by which the organism modifies its biochemical state requires information flow 
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between the organism and its environment. The information packet could be 
biomolecules, such as signaling molecules or nutrients, or physiochemical agents such 
as pH and temperature. The organism uses the information stored in its genetic material 
as well as its current biochemical state to bring about the required modifications to its 
biochemical state. The biochemical state is a reservoir of information and a component 
of the information repertoire of a cell. Other components of the information repertoire 
include spatial distribution of biomolecules, their chemical structures, and their 
conformational states. 
The proteome is one of the critical components of the biochemical state. In most 
of the biochemical processes, proteins, the building blocks of a proteome, act as 
molecular actuators providing essential biochemical activities. The proteome is very 
dynamic. New molecules are constantly being synthesized and old molecules degraded. 
Not all proteins are present at the same abundance levels. The cell needs to fine tune 
its synthesis and degradation machinery to maintain an optimal level of every protein in 
the molecule. The optimal levels of different proteins depend upon the external 
environmental conditions, or stimuli. 
An important motivation for studying the modification of proteome by 
environmental stimuli comes from the study of tumors and their microenvironments. The 
environmental conditions inside the tumor microenvironments are different from the 
physiological conditions at multiple levels  (Vaupel, Kallinowski, and Okunieff 1989; 
Mbeunkui and Johann Jr 2008; Trédan et al. 2007; Finger and Giaccia 2010; Song 
1984; Kessenbrock, Plaks, and Werb 2010; CHUNG et al. 2005; Hazlehurst, 
Landowski, and Dalton 2003; Kenny, Lee, and Bissell 2007; Whiteside 2008). Tumor 
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microenvironment has been found to promote tumor growth by activating survival 
pathways. It also helps tumor cells escape the host immune response (Whiteside 2008). 
The local tumor microenvironment allows cells in the tumor to crosstalk, which might 
contribute to continued survival signaling through autocrine loops (Mbeunkui and 
Johann Jr 2008). It can promote drug resistance by modulating the delivery of a drug or 
its stability (Trédan et al. 2007). The local tumor microenvironment has also been 
proposed to provide sanctuaries for subpopulations of tumor cells that facilitates 
acquisition of drug resistance (Hazlehurst, Landowski, and Dalton 2003). Essentially the 
tumor microenvironment expands the information repertoire of the tumors allowing the 
cells in it to escape the host machinery designed to inhibit uncontrolled cell growth.  
Another motivation for studying the effect of environmental stimuli comes from 
the goal of ensuring food security for an ever growing world population (Hanjra and 
Qureshi 2010; Rosegrant and Cline 2003; Fan et al. 2011; Godfray et al. 2010). To 
achieve that we need to develop strains of plants that can grow in a wide variety of 
stress conditions, such as drought, high salinity, and extreme fluctuations in 
temperatures, to name a few. This would require understanding the cellular responses 
to environmental stimuli (Chapin III, Autumn, and Pugnaire 1993; Apel and Hirt 2004; 
W. J. Chen and Zhu 2004; De Angelis and Gobbetti 2004; Mizoguchi, Ichimura, and 
Shinozaki 1997). 
Microarray based transcriptomic studies: The advent of high throughput 
technologies, for example microarrays, heralded a new era in the study of modifications 
of the information repertoire of the cells in response to environmental stimuli (Schena et 
al. 1995; Lockhart et al. 1996). Due to technological reasons the initial focus of these 
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studies was on the transcriptomic responses. One of the earliest systems level studies 
of the transcriptome involved its modulation by environmental stimuli in human cell 
culture models. In this study two stimuli were used, heat shock at 43 oC for 4 hours and 
growth in the presence of phorbol esters for 4 hours (Schena et al. 1996). . Comparison 
of the transcriptomic response to the two stimuli revealed distinct changes specific to 
them. The technique was later applied to study transcriptomic changes in cancer. A 
pioneering study identified characteristic changes in the transcriptome that 
accompanied tumor suppression (J. DeRisi et al. 1996). 
Budding yeast Saccharomyces cerevisiae was at the forefront of these studies. 
In one of the earliest studies transcriptomic studies, S. cerevisiae was used to study 
metabolic reprogramming in response to the changes in the nutrient availability (J. L. 
DeRisi, Iyer, and Brown 1997). A study with large numbers of stimuli revealed that there 
are common genes and pathways that are activated or repressed in response to all 
environmental stimuli. The authors called this group of genes the environmental stress 
response genes (Gasch et al. 2000). Although these studies provided important insights 
into modifications of the information repertoire of the transcriptome in responses to 
environmental stimuli, the translation of the insights to the proteome was not straight 
forward. Development of new technologies was needed for systems level study of the 
information repertoire of proteomes. 
Mass spectrometry based proteomics: Mass spectrometry is a very powerful 
technique for studying chemical composition and structure of molecules. Its utilization 
was initially limited because of the lack of a technique to ionize and get the 
biomolecules in gaseous state. Development of matrix assisted laser desorption 
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ionization (MALDI) and electrospray ionization (ESI) provided a handle to study 
biomolecules. Application of MALDI was first to be reported and was used to analyze 
molecules with up to 100 000 m/z (Tanaka et al. 1988). Soon after, the application of 
ESI to study oligonucleotides and proteins was reported (Fenn et al. 1989). Earlier the 
application of tandem mass spectrometry in sequencing proteins and peptides had been 
demonstrated (Hunt et al. 1986). In this study, enzymatic digestion of proteins to yield 
smaller peptides followed by liquid chromatography fractionation was used. The 
peptides were ionized using liquid secondary ion mass spectrometry (Hunt et al. 1986). 
These developments catalyzed rapid explosion in the application of mass spectrometry 
for studying large biomolecules, including proteins (Aebersold and Mann 2003; Yates, 
Ruse, and Nakorchevsky 2009). 
The mass spectrometers used in proteomics studies have also undergone rapid 
improvements over the last two decades. It has included improvements in resolution 
and mass accuracy as well as improved ion optics and data acquisition speeds (Yates, 
Ruse, and Nakorchevsky 2009; Walther and Mann 2010; Smith 2002; X. Han, Aslanian, 
and Yates III 2008; Michalski et al. 2011; Senko et al. 2013). These improvements are 
allowing study of proteomes at ever greater depth (Kim et al. 2014; M. Wilhelm et al. 
2014).  
A feature of ESI is that ions are generated from a solution. This allows inline 
coupling of an ESI source to liquid chromatography systems for separation of peptides. 
Liquid chromatography tandem mass spectrometry is the most widely used technology 
in proteomics for both protein identification and quantitation (Rudnick et al. 2010). 
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Quantitative proteomics approaches: In the last decade the focus of mass 
spectrometry based proteomics has shifted towards quantitative studies from the 
generation of catalogs of protein identifications (Altelaar, Munoz, and Heck 2013; Ong 
and Mann 2005; Bantscheff et al. 2007; Bantscheff et al. 2012; Larance and Lamond 
2015). A number of techniques have been developed for quantitation using mass 
spectrometry. The techniques can be broadly divided into two categories – (1) label free 
and (2) labeling based. Alternatively, the techniques can be divided into categories 
based upon whether the quantitation is done using precursor ions or the fragment ions. 
In this case too there can be two categories – (1) precursor ion based and (2) fragment 
ion based. 
Label free approaches have been the most popular quantitative approach due to 
the ease of sample preparation and a reduced cost of running experiments. Examples 
of label free approach include quantitation using area under the curve of precursor ion 
intensities, as a peptide is detected during elution from the liquid chromatography 
column, and spectral counting (Neilson et al. 2011). Label free approaches have lower 
precision and accuracy that led to the development of a number of isotopic labeling 
approaches. The isotope labels can be added metabolically as in the stable isotope 
labeling by amino acids in cell culture (SILAC) and Neutron encoding stable isotope 
labeling by amino acids in cell culture (NeuCode SILAC) (Hebert et al. 2013; Ong et al. 
2002). It can also be added chemically as in isobaric tag for relative and absolute 
quantitation (iTRAQ), isotope coded affinity tag (ICAT), tandem mass tag (TMT) and 
mass-coded abundance tagging (MCAT) (Ross et al. 2004; Gygi et al. 1999; Thompson 
et al. 2003; Cagney and Emili 2002). 
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TMT and iTRAQ are isobaric tagging approaches in which quantitation is done 
using the fragment ion intensities (Thompson et al. 2003; Ross et al. 2004). The tags 
are designed in such a way that the mass added to the tagged peptides is the same 
across the set of samples being analyzed together. This allows co-isolation and 
fragmentation of peptides in the mass spectrometers. Peptide fragmentation releases 
reporter ions whose masses differ from each other. The reporter ion intensity is 
proportional to the amount of peptide in the samples. Since peptides from all the 
samples in a set are sampled at the same point in time, comparing the ratios of the 
reporter ions provides a measure of relative quantitation of the peptides. If a common 
control sample is used in one of the reporter ion channels, any number of samples can 
be quantitated relative to a common control (Hoek et al. 2015). Similar experiment 
designs have been developed with precursor level quantitation approaches for large 
scale quantitative proteomics approaches(Geiger et al. 2010).  
The advances in mass spectrometry based quantitative proteomics have been 
critical for the systems level studies of the information repertoire of the proteomes. 
Information in the proteome is encoded through abundances of proteins, their post-
translational modifications, and spatial localization of the molecules. Mass spectrometry 
based proteomics is revolutionizing the research in every aspect of biology (Yates, 
Ruse, and Nakorchevsky 2009; Stastna and Van Eyk 2012; Clancy and Hovig 2014; 
Choudhary and Mann 2010; Drissi, Dubois, and Boisvert 2013; Gajadhar and White 
2014; Y. Zhang et al. 2013; Hennrich and Gavin 2015; Altelaar, Munoz, and Heck 2013; 
Breker and Schuldiner 2014). 
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Studying protein abundance changes: The cellular abundance of proteins is one 
feature of the information repertoire encoded through the proteome. The abundances of 
specific proteins are changed in response to an environmental stimulus (Feder and 
Hofmann 1999; Lindquist 1986; Blokhina, Virolainen, and Fagerstedt 2003; Roth, 
Roepenack-Lahaye, and Clemens 2006). Some of the changes lead to synthesis of 
proteins that are needed for responding to the stimulus, for example heat-shock 
proteins upon heat-shock (Feder and Hofmann 1999). Others might lead to a 
downregulation, for example that of pro-inflammatory receptors to avoid tissue damage 
(Ohta and Sitkovsky 2001). The goal of systems biology is to understand the 
contributions of all the components of an organism towards its continued survival and 
adaptation to new environments (Kitano 2002; Kitano 2000; Ideker, Galitski, and Hood 
2001). Understanding the global protein level changes is a minimum requirement 
towards fulfilling the goals of systems biology. Mass spectrometry based proteomics 
has been one of the most widely used approaches in this area. 
In one of the earliest applications of quantitative proteomics, ICAT was used to 
study the differences between the steady state proteomes of S. cerevisiae cells growing 
with either ethanol or galactose as carbon source. The differences in expression of two 
isoforms of alcohol dehydrogenase, ADH1 and ADH2 that are 93% identical at the 
amino acid sequence level, were determined. These differences were similar to the 
predicted differences based upon their distinct functions in carbon metabolism (Gygi et 
al. 1999). Soon after another stable isotope labeling approach for quantitation, SILAC, 
was used to study muscle differentiation in cell culture using C2C12 myoblasts (Ong et 
al. 2002). Quantitative proteomics is also a popular method to study proteomic changes 
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in cancer (Ong and Mann 2005; Xu et al. 2008; Everley et al. 2004; Hanash, Pitteri, and 
Faca 2008; Wulfkuhle, Liotta, and Petricoin 2003). Multiple reaction monitoring 
approach has been used to determine the abundances of proteins present in 41 copies 
per cell to more than a million copies per cell (Picotti et al. 2009). 
In another study, the proteomic changes with either carbon or nitrogen limitation 
in S. cerevisiae was assayed using N15 labeling in chemostat cultures. This study 
identified 102 differentially expressed proteins; many of those changes were expected 
based upon previous studies. The proteins that were upregulated in carbon limitation 
showed good correlation with the transcriptomic changes. However, the proteins that 
were upregulated in nitrogen limitation did not correlate well with the transcriptomic 
changes. This suggested a transcriptional regulation of carbon source limitation 
response while the predominant mode of regulation in response to nitrogen limitation 
was either translational or degradation controlled (Kolkman et al. 2006).  
A perturbation study, where one of the environmental parameter is perturbed 
keeping everything else constant, is a powerful technique. It allows us to find the 
changes in the biochemical state in response to the perturbation. However, cells in their 
native environment are rarely subject to single discrete changes in their environment. 
Therefore the application of this approach in modeling complex cellular responses in 
native conditions is limited. One way to expand the power of this approach would be to 
perform combinatorial perturbation analysis where multiple environmental stimuli are 
applied concurrently. 
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Cellular responses to combinatorial stimuli: Combinatorial effects of compounds 
have been an active area of research in toxicology, drug combination therapy, and 
environmental science (Greco, Bravo, and Parsons 1995; Altenburger et al. 2013; 
Altenburger, Nendza, and Schüürmann 2003; Altenburger et al. 2012; Altenburger, 
Walter, and Grote 2004; Faust et al. 2001; Ankomah and Levin 2012; GARDNER 2002; 
Berenbaum 1989; Deneer 2000; Schoen 1996; Hermens, Leeuwangh, and Musch 
1985). Most of these studies focused on one aspect of the cellular responses such as 
mixture toxicity or therapeutic effect of a combination of drugs. However, there have 
been only a limited number of systems level studies of cellular responses to multiple 
concurrent stimuli. Most of these have been transcriptomic studies. 
In a pioneering study of transcriptomic changes in response to combinatorial 
changes in the environmental stimuli, regression analysis was used to interpret the 
observed changes. In this study 10 environmental parameters were varied. The total 
number of unique conditions was 55 and the total number of experiments was 170. 
Combinatorial stimulus was found to have profound effect on the expression pattern 
(Knijnenburg et al. 2009). The same analysis approach was also used in a study of 
transcriptomic responses of Arabidopsis thaliana liquid cultures to concurrent stimuli. In 
this study, the stimuli were high salinity and carbon dioxide concentration (Kanani, 
Dutta, and Klapa 2010). Although the regression models were able to explain significant 
amount of the statistical variances in the two studies, a biological interpretation was not 
straightforward. 
In a more recent study, the combinatorial effects of high NaCl and pheromone 
signaling was assayed in S. cerevisiae (Vaga et al. 2014). Phosphorylation events were 
 11 
 
used as measures of activation/repression of specific signaling pathways. A set of 
ordinary differential equations were used to build logic models describing the integration 
of signaling through the high osmolarity and mating signaling pathways. This approach 
identified complex interconnections between the two pathways. However, similar to the 
regression approach above, a biological interpretation of the data is not straightforward. 
This motivated me to explore approaches that can be used to precisely and accurately 
model the combinatorial responses and at the same time have a simpler biological 
interpretation. 
I searched upon the conceptual framework of gene interactions that can be easily 
applied to the study of environmental stimuli (P. C. Phillips 1998). As an abstraction a 
gene is a packet of information, so is an environmental stimulus. A gene has an effect 
on the information repertoire of the cell when the information stored in it is used to build 
functional molecules such as regulatory RNAs or proteins. In cells the products of 
multiple genes carry the information from their respective genetic loci. The information 
from genes travels through the information networks inside cells. The interaction 
between the gene products, or sometimes a lack of interaction due to a loss of function, 
integrate the information and modify the information repertoire of the cells. The 
information for modification comes from within the cells, its genetic material. In the case 
of an environmental stimulus, the information from outside the cell travels through the 
cellular information network to modify its information repertoire. If multiple stimuli are 
present, the information from each of them would be integrated inside the cellular 
information network.  
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As an abstraction, this integration of information could be similar to the 
integration of information from genes through gene interactions. Therefore, the 
conceptual framework of gene interactions can be used to study the combinatorial effect 
of concurrent environmental stimuli. I called it the concepts of environmental 
interactions and environmental epistasis. I defined an environmental interaction as the 
interaction between different environmental stimuli that affect the same observable 
characteristic or trait. In this schema, environmental epistasis is a special case of 
environmental interaction in which the effects of the individual stimuli are not 
independent of each other. We have tested the applicability of this approach in studying 
the effects of multiple concurrent environmental stimuli in S. cerevisiae (Samir et al. 
2015). 
Regulation of the proteome by the ribosomes 
The information stored in the genome is the template used to build the 
information repertoire stored in a proteome. It involves encoding of the information into 
an intermediate class of molecules called messenger RNAs (mRNAs) followed by 
translation of the information from mRNAs into amino acid sequences of proteins 
through a process called translation. Translation consists of 4 steps: (1) initiation, (2) 
elongation, (3) termination, and (4) recycling. A host of proteins and RNAs regulate 
these steps (Kapp and Lorsch 2004). The catalytic engine of this process is the 
ribosome. The eukaryotic ribosome consists of a 60S large ribosomal subunit and a 40S 
small ribosomal subunit. The large subunit has three rRNA molecules (28S, 5.8S and 
5S) and 46 ribosomal proteins. The small subunit is made up of a single rRNA (18S) 
and 33 ribosomal proteins (Jonathan R Warner 1999; Nakao, Yoshihama, and 
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Kenmochi 2004). The catalytically competent fully functional 80S ribosome is a 
heterodimeric complex of the small and large subunits.  
Ribosomes are assembled inside the nucleus through a process called ribosome 
biogenesis. Ribosome biogenesis is one of the most energy intensive processes. In 
eukaryotes requires concerted action of hundreds factors, including proteins and small 
nucleolar RNAs (snoRNAs) (J. Woolford 2015; J. L. Woolford and Baserga 2013; de la 
Cruz, Karbstein, and Woolford Jr. 2015; Turowski and Tollervey 2014; Planta 1997; 
Boisvert et al. 2007; J. R. Warner 1989). RNA Pol I transcribes the pre-rRNA whose 
endolytic processing generates 28S, 18S, and 5.8S rRNAs. RNA Pol III transcribes 5S 
rRNA (Kressler, Linder, and Cruz 1999; Venema and Tollervey 1999; Granneman and 
Baserga 2004; Nazar 2004). During ribosome biogenesis, pre-RNA is processed and 
the ribosomal proteins sequentially added (Gamalinda et al. 2014). Once the ribosomal 
subunits have been assembled, they are exported out of the nucleus and undergo a 
final round of processing before joining the free ribosomal subunit pool primed to start 
translation (Johnson, Lund, and Dahlberg 2002; Rouquette, Choesmel, and Gleizes 
2005; Zemp and Kutay 2007; van Riggelen, Yetil, and Felsher 2010). 
In the first step of translation, translation initiation factors help assemble a 
functional ribosome on an mRNA (Kapp and Lorsch 2004). Eukaryotic mRNAs contain 
5’ cap structure in which a guanosine nucleotide is connected through 5’-5’ bond. This 
guanosine is also methylated on position 7. The cap acts as the start beacon, among its 
many functions (Shatkin 1976). It helps recruit eIF4 initiation factors to the mRNA. The 
eIF4 complex unwinds the secondary structures on the mRNA and helps recruit the 43S 
preinitiation complex (PIC) (Gingras, Raught, and Sonenberg 1999, 4). PIC consists of 
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40S ribosomal subunit bound to eIF2 and initiator Met-tRNA. eIF2 in PIC is bound to 
GTP.  The 40S subunit scans the mRNA to find the initiation AUG codon. The 40S 
ribosome starts scanning the mRNA to find the initiation AUG codon. Once the initiation 
codon has been identified, the GTP bound to eIF2 is hydrolyzed and eIF2 dissociates 
from the complex. This paves way for recruitment of the 60S ribosomal subunit leading 
to the formation of a fully functional ribosome and translation elongation can begin 
(Hinnebusch 2005; Kapp and Lorsch 2004; Sonenberg and Hinnebusch 2009; Gingras, 
Raught, and Sonenberg 1999; Korostelev 2014).  
The cap-dependent mode of translation initiation discussed above is the 
predominant mode of translation initiation. In addition, a cap-independent translation 
initiation mechanism can also be employed by some mRNAs (Merrick 2004). In cap 
independent translation initiation, the ribosomes are recruited directly to an internal 
ribosome entry site (Merrick 2004; Pelletier and Sonenberg 1988; Jang et al. 1988; 
Chappell, Edelman, and Mauro 2000). Some viruses exploit this mechanism of 
translation by shutting down the cap-dependent translation that shuts down most of the 
host protein synthesis. This allows viral protein synthesis to occur using a cap-
independent mechanism (Sk et al. 1989; Firth and Brierley 2012; Boehringer et al. 2005; 
Fernández et al. 2014).   
Once the 80S ribosome is assembled on an mRNA, translation elongation can 
begin (Kapp and Lorsch 2004). This phase of translation requires two elongation 
factors, eEF1 and eEF2, and tRNAs charged with cognate amino acids. tRNAs are the 
keys for decoding the information from mRNA. They contain three letter anticodon key 
that is complementary to the three letter codons on mRNA. The elongation factor eEF1 
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facilitates the entry of charged tRNA to the free ribosome acceptor site as well GTP 
hydrolysis upon correct anticodon-codon base pairing. Upon correct anticodon-codon 
base pairing, a new peptide bond is formed to extend the length of the nascent 
polypeptide through peptidyl transferase reaction. The peptidyl transferase catalytic 
activity resides in the 28S rRNA component of the 60S large ribosomal subunit, making 
ribosome an example of ribozyme. Another molecule of GTP is consumed by eEF2 
elongation factor for translocating the ribosome three nucleotides once the peptidyl 
transfer reaction has occurred. This ensures that information from the mRNA is 
decoded sequentially three nucleotides at a time. GTP hydrolysis helps in reducing the 
errors during translation elongation as well as provides directionality (Kapp and Lorsch 
2004; G. R. Andersen, Nissen, and Nyborg 2003; Nilsson and Nissen 2005; Nyborg and 
Liljas 1998; Frank 2012). 
Translation elongation continues till the ribosome encounters one of the stop 
codons - UAA, UAG, and UGA. The stop codons mark the end of the message in the 
mRNAs. There are no tRNAs for any of the stop codons. Instead, the translation 
termination factor eRF1 is recruited to the free acceptor site on the ribosome followed 
by the binding of another termination factor eRF3 (Kapp and Lorsch 2004; Dever and 
Green 2012). The termination factor eRF1 can recognize all of the three stop codons. 
Once it has ensured that the ribosome has reached a stop codon, it catalyzes the 
peptide release from the ribosomes. Although peptide release can be catalyzed by 
eRF1 alone, presence of eRF3 greatly increases the reaction rate. The cooperative 
actions of eRF1 and eRF3 ensure proper and speedy translation termination. After 
peptide has been released the complex of tRNA, termination factors, ribosome, and the 
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mRNA is known as post-termination complex (Dever and Green 2012; Georges et al. 
2014; Inge-Vechtomov, Zhouravleva, and Philippe 2003, -). 
The final step in translation is recycling of the ribosomes from the post-
termination complex to start another round of translation. This is also the least 
understood phase in translation, especially in eukaryotes. There are two fates possible 
for the ribosome bound to the mRNA after termination – (1) it can reinitiate translation at 
a downstream start codon, or (2) it can be dissociated from the mRNA making it 
available for another round of translation. Both possibilities have been found to be 
utilized in cells, albeit the latter being more frequent than the former (Nürenberg and 
Tampé 2013; D. J. Young et al. 2015; S. K. Young et al. 2015; Dever and Green 2012; 
Jackson, Hellen, and Pestova 2012; Franckenberg, Becker, and Beckmann 2012). 
In the traditional model of translational control, all powers to regulate are invested 
in the protein and RNA accessory factors, and the ribosomes are considered passive 
players. Most studies of translational control have focused on such regulatory 
molecules. This effort has led to the identification of the core components of 
translational control and a better understanding of this process (Kapp and Lorsch 2004; 
Dever and Green 2012; Sonenberg and Hinnebusch 2009; Hinnebusch 2015). In recent 
years, the idea that the ribosomes are regulatory elements in gene expression 
regulation has been gaining ground. The role of ribosome in the regulation of gene 
expression is a very active area of research (Ruggero and Pandolfi 2003; Kondrashov 
et al. 2011; Xue et al. 2015; Jonathan R. Warner and McIntosh 2009; Jonathan R. 
Warner 2015; McIntosh and Warner 2007; Komili et al. 2007). This idea was nucleated 
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due to the observation of heterogeneity in the ribosomal sub-populations in cellular 
slime molds (S. Ramagopal 1992). 
Ribosome heterogeneity: Heterogeneity in ribosome composition has been known 
since the early work with E. coli ribosomes (Kurland et al. 1969). Soon after studies in 
rat revealed the differences between the protein composition of ribosomes from muscle 
and liver (Sherton and Wool 1974). Studies in cellular slime mold Dictyostelium 
discoideum revealed three modes of heterogeneity (S. Ramagopal 1992). In the first 
mode, some ribosomal proteins were found to be exclusively present in the vegetative 
or differentiated state. Two of the ribosomal proteins were present only in the vegetative 
state, while three only in the differentiated spores (S. Ramagopal 1992; Subbanaidu 
Ramagopal and Ennis 1981). In the second mode, some ribosomal proteins were 
present in varying stoichiometries in different developmental stages (Subbanaidu 
Ramagopal and Ennis 1981; S. Ramagopal 1992). These modes of generating 
ribosomal heterogeneity were found to be conserved across several cellular slime mold 
species (Subbanaidu Ramagopal and Ennis 1984). A third mode of heterogeneity 
generation involved differential post-translational modifications of ribosomal proteins.  In 
Dictyostelium discoideum, ribosomal proteins were found to be methylated or 
phosphorylated. Many of the modifications were specific to vegetative cells or starvation 
induced aggregation competent cells (S. Ramagopal 1992; S. Ramagopal 1991). The 
fact the heterogeneity was present in growth stage specific manner suggested a 
functional significance of heterogeneity. 
In a more recent study in A. thaliana, liquid chromatography tandem mass 
spectrometry analysis of protein composition of ribosomes revealed changes in 
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composition in response to sucrose feeding. Some of the changes in composition 
involved paralogous ribosomal proteins. Paralogous ribosomal proteins may have 
arisen through gene or whole genome duplications and are nearly identical to each 
other. In A. thaliana, 231 ribosomal protein genes code for ribosomal proteins. Each 
ribosome contains 79 proteins (Hummel et al. 2012). The presence of paralogs provides 
a mechanism of generating ribosomal heterogeneity through a specific use of paralogs 
in A. thaliana ribosomes (Nakao, Yoshihama, and Kenmochi 2004). 
In S. cerevisiae too there are 59 ribosomal protein paralog pairs (Nakao, 
Yoshihama, and Kenmochi 2004). Therefore, the presence of paralog can allow 
heterogeneity in the ribosomal populations also in S. cerevisiae. In a study involving 
oxidative stress, RPL22A and RPL16B were found to be upregulated in response to 
hydrogen peroxide treatment (Chan et al. 2012). A mutational analysis revealed that 
loss of rpl22a but not rpl22b leads to sensitivity to the oxidative stress. The other 
paralog pair, RPL16A and RPL16B, did not show sensitivity to oxidative stress 
suggesting a functional complementation between them (Chan et al. 2012). The lack of 
functional complementation between RPL22A and RPL22B suggest a functional role for 
paralog mediated ribosomal heterogeneity in translational control. 
The ribosome filter hypothesis: The ribosome filter hypothesis was proposed in light 
of the observations that some mRNAs contained regions that were similar or 
complementary to 18S or 28S rRNAs (Vincent P Mauro and Gerald M Edelman 2007). It 
was expanded to include ribosomal protein mediated interactions with the mRNAs. The 
underlying idea is that the ribosomes with different compositions translate specific 
mRNAs with differing efficiency (Figure 1) (Mauro and Edelman 2002; Vincent P Mauro 
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and Gerald M Edelman 2007). There are four basic tenets of the hypothesis that I am 
reproducing here – “(1) the ribosome is a regulatory structure that embodies 
mechanisms for preferentially translating different subsets of the message population, 
(2) ribosomes may display a continuum of regulatory effects, (3)  competition  for  
binding  sites  in  ribosomal  subunits  may affect  the  rate  of  translation  of  different  
mRNAs, and (4)  the  filter  may  also  be  modulated  as  a  result  of  altering  or 
masking  particular  binding  sites  on  ribosomes” (Mauro and Edelman 2002; Vincent P 
Mauro and Gerald M Edelman 2007). 
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Figure 1 - The ribosome filter hypothesis. 
A) A cartoon showing that two ribosomes in differing composition translate a transcript with different 
efficiencies. The dark ribosome is more efficient than the light ribosome. B) A cartoon showing the 
presence of heterogeneous subpopulations of ribosomes differing in their composition. To efficiently 
translate two different proteomes, two different subpopulations of ribosomes are needed. 
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The depot hypothesis: The depot hypothesis was proposed to explain the 
extra-ribosomal functions of ribosomal proteins (Ray, Arif, and Fox 2007). In one of the 
earliest examples of extra-ribosomal function of a ribosomal protein, RPL13A was found 
to inhibit translation of ceruloplasmin (Cp) mRNA (Mazumder et al. 2003). RPL13A is a 
component of interferon-Gamma Activated Inhibitor of Translation (GAIT) complex that 
binds to GAIT element in the 3’UTR of Cp mRNA (Mazumder et al. 2003; R. 
Mukhopadhyay et al. 2009). Under normal conditions, RPL13A remains associated with 
the 60S subunit of the ribosomes. It is phosphorylated in response to interferon-Gamma 
singling. Phosphorylation is the trigger for its dissociation from the ribosome. The free 
phosphorylated protein binds to the GAIT element to inhibit translation of target mRNAs 
(Mazumder et al. 2003). This observation led to the authors “to propose a ‘depot 
hypothesis’ in which macromolecular assemblies, while maintaining their ordinary 
activity, acquire the non-canonical capability to release component proteins that perform 
new functions outside the complex” (Ray, Arif, and Fox 2007). 
A number of examples of ribosomal proteins have been described in addition to 
the one described above (Jonathan R. Warner and McIntosh 2009). In mammals, S27-
like and S27 have been found to inhibit MDM2 mediated ubiquitination of p53 (Xiong et 
al. 2011). In A. thaliana, phosphorylation of RPL10 causes it to translocate to nucleus 
where it is hypothesized to be involved in host defense against virus infection (Carvalho 
et al. 2008). These examples suggest a frequent utilization of ribosomal proteins in 
functions outside their primary function in translation as predicted by the depot 
hypothesis. The ribosome filter and depot hypothesis have a human disease element 
too. 
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The ribosomopathies: Ribosomopathies have been defined as “a collection of 
disorders in which genetic abnormalities cause impaired ribosome biogenesis and 
function, resulting in specific clinical phenotypes” (Narla and Ebert 2010). The earliest 
example of a ribosomopathy is a human disease Diamond Blackfan Anemia (DBA) 
(Jonathan R. Warner 2015; Narla and Ebert 2010). Mutations in RPS19 locus were 
found to be associated with DBA. The types of mutation included nonsense, frameshift, 
splice site, and missense mutations (Draptchinskaia et al. 1999). Since then mutations 
in 11 ribosomal protein genes have been found to be associated with DBA (Aspesi et al. 
2014). 
Since discovery of mutations in ribosomal proteins in DBA, a number of other 
ribosomopathies have identified. One example is X-linked Intellectual Disability caused 
by the mutation in RPL10. The mutant protein is still functional and is able to 
complement the conditional mutant of RPL10. The missense mutation also led to an 
increase in actively translating ribosomes (Zanni et al. 2015). Mutation in RPS20 was 
found to cause predisposition to Hereditary Nonpolyposis Colorectal Carcinoma 
(Nieminen et al. 2014). The list of ribosomopathies is growing with new mutations and 
diseases continuously being found to be associated with each other (Narla and Ebert 
2010; Jonathan R. Warner 2015; Yelick and Trainor 2015; Danilova and Gazda 2015; 
Amanatiadou et al. 2015; Brooks et al. 2014; Ruggero and Pandolfi 2003; Yang et al. 
2015; Martin et al. 2014). These studies are providing added motivation for studying the 
regulatory functions of ribosomes. 
In this study, I used changes in protein composition of S. cerevisiae ribosomes in 
response to a change in carbon source to identify candidate ribosomal proteins that 
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might be playing a role in ribosome filter mediated translational control. I used iTRAQ 
based quantitative proteomics and cryo-EM, in collaboration with the Joachim Frank lab, 
to study the changes in composition of ribosomes both at the population as well as 
single particle levels. I identified 11 such proteins that includes a paralog pair, Rpl8a 
and Rpl8b, using quantitative proteomics. I am using yeast genetics, biochemistry, and 
next-generation sequencing in follow up experiments to dissect the exact mechanism of 
ribosome filter mediated translational control. 
The proteome in myotonic dystrophy 
 Myotonic dystrophy (dystrophia myotonica, DM) is an autosomal dominant 
progressive multisystemic disorder caused by expansion of microsatellite repeats 
(Thornton 2014). It is the most common form of adult muscular dystrophy (Udd and 
Krahe 2012). DM was first described by Steinert, Batten and Gibb in 1909 (Schoser and 
Timchenko 2010). It was later recognized as a multisystemic disorder with the 
observation of a high incidence of cataracts in DM patients (Schoser and Timchenko 
2010). DM is characterized by progressive muscle weakness, myotonia, cataracts, and 
cardiac conduction defects (Udd and Krahe 2012; Thornton 2014; Machuca-Tzili, Brook, 
and Hilton-Jones 2005; Turner and Hilton-Jones 2014). 
The causative agent for DM was identified as an expansion of CTG repeat 
element in the 3’ untranslated region of dystrophia myotonica-protein kinase (Brook et 
al. 1992; Mahadevan et al. 1992; Y. H. Fu et al. 1992). Shortly afterwards, many cases 
of DM were described that lacked the CTG expansion (Thornton, Griggs, and Moxley 
1994; Ricker K et al. 1995; Ricker et al. 1994; Udd et al. 1997; Meola et al. 1996). 
These patients typically had a milder form of the disease. Since the proximal muscles 
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are involved in this form of the disease, instead of the distal muscles in the previously 
described form, it was named proximal myotonic myopathy. The two forms of the 
disease were later renamed as myotonic dystrophy type 1 (DM1) and myotonic 
dystrophy type 2 (DM2). DM1 patients had the CTG repeat expansions. DM2 was 
subsequently found to be caused by a CCTG tetranucleotide repeat expansion in the 
first intron of Znf9 gene. 
Myotonic dystrophy type 1 (DM1): DM1 is the classic form of the disease that was 
first described more than a hundred years ago. DM1 can present in four different forms: 
adult onset, congenital, childhood onset, and late onset oligosympotomatic. The age of 
onset negatively correlates with the repeat size. The adult form is the most typical form 
while the congenital form is the most severe form of DM1 (Udd and Krahe 2012). DM1 
is more prevalent in European populations, where it ranges from 1:1100 in Finland to 
1:10700 in other countries (Thornton 2014). It was found to be a rare disease in Taiwan 
and sub-Saharan Africa. In Taiwan the disease incidence was found to be 0.46:100000 
(Hsiao et al. 2003). Incidences of DM1 in Africa in non-European populations were very 
rare. For example, only one DM1 family was identified in Nigeria, when the population of 
country was 120 million. The same study revealed that DM1 was more prevalent in 
Europe, Japan, Southwest Asia and India. It was less prevalent or extremely rare in 
West African, Bantu, Ethiopian, Tunisian Berbers, Southern Chinese, Thai and non-
European Australians (Ashizawa and Epstein 1991).  
 The molecular basis of DM1 was independently identified by three groups 
(Mahadevan et al. 1992; Y. H. Fu et al. 1992; Brook et al. 1992). Interestingly, one of 
the studies mistakenly identified the repeat to be a GCT repeat. They were using GCT 
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repeat synthetic oligonucleotides as probes in their experiment. An oligonucleotide with 
repeated GCT sequences is virtually identical to a CTG repeat sequence, except the 
ends, that confounded their interpretation (Y. H. Fu et al. 1992). Previous studies had 
identified the long arm of chromosome 19 to contain the locus that was in linkage 
disequilibrium with DM1 (Korneluk et al. 1989; Brunner et al. 1989; Shaw et al. 1986; 
Smeets et al. 1990; Aslanidis et al. 1992). Other two studies used a positional cloning 
strategy to clone the previously identified DM1 locus and identified the CTG repeat 
expansions as the causative agent (Brook et al. 1992; Mahadevan et al. 1992). The 
number of repeats in normal individuals was found to vary between 5 and 30. In DM1 
patients, the number of repeats exceeded 50 (Brook et al. 1992; Mahadevan et al. 
1992). 
 CTG repeats are highly unstable. In one study only 4 out of 110 cases 
were identified where the repeats were passed on unchanged from the parental 
generation. In the same study, the repeat expansions by more than 400 in a single 
generation were observed (Redman JB et al. 1993). The repeats are also biased 
towards expansion (Thornton 2014; Redman JB et al. 1993; Temmerman et al. 2004). 
There is also a pronounced maternal expansion bias (Pearson, Edamura, and Cleary 
2005). Different mechanisms for expansions have been proposed that include genome 
duplication errors, genome maintenance error in quiescent state or recombination 
defects during meiosis (Pearson, Edamura, and Cleary 2005).  
A high amount of somatic instability in CTG repeat length suggests a prominent 
role for errors in genome maintenance or duplications that occur after meiosis (Loreto 
Martorell et al. 1997). A comparison between the repeat lengths of identical twins 
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showed different patterns of expansion in one of the two pairs (de Munain et al. 1994). 
The repeat was also found to expand with time in the same individual (L. Martorell et al. 
1995). A number of studies have reported variable length of the repeats in different 
tissues of the same individuals (Thornton, Johnson, and Moxley 1994; Shelbourne et al. 
1992; Lavedan et al. 1993; G. Jansen et al. 1994). Interestingly, repeat contraction was 
reported in a father-son pair with repeat length falling to the normal range for the son 
who did not have the disease (Shelbourne et al. 1992). In one of the studies, CTG 
repeats were found to be larger in skeletal muscles compared to leukocytes (Thornton, 
Johnson, and Moxley 1994). Taken together, it suggests a more prominent role for 
errors in genome maintenance during mitosis or quiescence in repeat expansion. 
Myotonic dystrophy type 2 (DM2): DM2 was described shortly after identification of 
CTG repeat expansion as the cause for classical DM. Although DM1 and DM2 are 
similar in their symptoms, and being a RNA dominant disorder, there are important 
differences between the two. DM2 is a relatively milder form of DM. DM2 does not 
involve a severe central nervous system defect. It is primarily a late onset disease. A 
congenital form of DM2 has not been observed. (Thornton 2014; Machuca-Tzili, Brook, 
and Hilton-Jones 2005; Turner and Hilton-Jones 2014, -; Cho and Tapscott 2007; 
Ulane, Teed, and Sampson 2014; Ranum and Day 2002). The numbers of 
tetranucleotide CCTG repeats are below 30 for normal individuals while they vary 
between 75 and 11000 in affected individuals making it much larger than the ones 
observed in DM1 (Liquori et al. 2001). Surprisingly, the repeat length has not been 
found to be associated with the age of onset or severity of the disease (Ranum and Day 
2002).  
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In normal individuals CCTG repeats are interrupted by GCTG motif, TCTG motif, 
or both (Kurosaki et al. 2012; Liquori et al. 2003). The repeat tracks are polymorphic 
with the form (TG)n(TCTG)n(CCTG)n(NCTG)n(CCTG)n (Bachinski et al. 2009). In 
affected individuals, only the CCTG motif of the repeat expands (Kurosaki et al. 2012; 
Day et al. 2003; Liquori et al. 2001; Bachinski et al. 2009). The repeats are very 
instable. They can contract as well as expand over generations (Kurosaki et al. 2012; 
Day et al. 2003; Ulane, Teed, and Sampson 2014). Nuclear magnetic resonance 
spectroscopy showed that the CCTG repeats are prone to forming metastable hairpin 
and dumbbell structures. The structures were shown to undergo dynamic 
conformational exchange. Both the structures were also found to contain flexible stem 
(Lam et al. 2011). In another study, it was found that the DM2 repeats are 
recombination hotspots. This process might be driven by DNA repair mechanisms (Dere 
and Wells 2006). The repeat itself was proposed to have originated from an insertion of 
Alu elements in the ZNF9 gene. The normal repeat structure was found to be conserved 
in primates, mouse, and rat (Kurosaki et al. 2012; Liquori et al. 2003).  
 In contrast to DM1, which has a relatively broader geographical 
distribution, DM2 seems to be more prevalent in European Caucasians. DM2 is more 
common in Northern European ancestry. Extensive haplotype analysis suggested that 
DM2 spread from a common founder (Liquori et al. 2003). More recently, a DM2 patient 
was identified in Japan. Haplotype analysis suggested that the DM2 repeat in this 
individual originated separately from those in European populations (Saito et al. 2007). 
There have been incidences of DM2 in non-European individuals in Morocco, Algeria, 
Lebanon, Afghanistan and Sri Lanka (Saito et al. 2007). 
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Molecular mechanisms behind DM pathogenesis: DM is classified as a RNA-
dominant disease (Osborne and Thornton 2006). The disease is thought to be caused 
by sequestration of essential RNA binding proteins by toxic RNA that contains the 
repeat elements in their non-coding region. Although this is now a universally accepted 
mechanism with certain modification, it was not always so clear. In an aptly titled review, 
“Myotonic dystrophy: will the real gene please step forward! “, Sarah Harris, Colin 
Moncrieff, and Keith Johnson expressed the frustrations of researchers in finding the 
molecular mechanism of the pathology (Harris, Moncrieff, and Johnson 1996). This was 
years after identification of CTG repeat expansion as the disease causing agent. A 
number of putative mechanisms had been proposed that explained some aspect of 
pathogenesis but not all. In addition, a new type of DM, DM2, had recently been found 
that did not contain the CTG repeat expansions. 
A number of pathogenic mechanism models have been proposed, many of them 
might contribute to the disease (J. E. Lee and Cooper 2009). Shortly after identification 
of the repeats, a haploinsufficiency model was proposed. In this model, the decrease in 
the amount of DMPK protein leads to pathogenesis. This model was supported by the 
observation that DMPK protein and mRNA levels were decreased in DM1 patients (Y.-
H. Fu et al. 1993). Follow up studies in mouse models suggested that although the 
decrease in DMPK protein levels might be contributing to the disease; it was not the 
sole cause. In one of the study, the mice null for Dmpk  had only mild phenotype (Gert 
Jansen et al. 1996). In another study, Dmpk null mice developed late onset myopathy, 
but did not show all the abnormalities observed in DM1 patients (Reddy et al. 1996). 
 29 
 
Furthermore, a loss of function mutation in DMPK has not yet been identified suggesting 
that a decrease in DMPK is not the sole cause of DM1 (J. E. Lee and Cooper 2009). 
DMPK locus lies in a very gene rich region of the genome. Using this information 
it was proposed that the repeat expansion is affecting the expression of adjacent genes. 
In one of the studies condensed chromatin was found downstream of DMPK gene 
(Otten and Tapscott 1995). This suggested that the transcription of genes in the vicinity 
would be decreased. This was indeed found to be a case where the expression of a 
candidate homeodomain gene DMAHP (also known as SIX5) was reduced in DM1 
patients. However in a study in mice, knocking out Six5 led to development of cataract 
without apparent abnormalities in the skeletal muscles (Klesert et al. 2000). This 
suggested that the effect of repeat expansion on the chromatin and transcription of 
neighboring genes might be a contributing factor, not the primary one in DM1 
pathogenesis. 
The failure of other models to explain all the clinical features of DM1 lead to the 
proposition of RNA dominance model (Osborne and Thornton 2006). It is also called 
RNA gain-of-function and RNA toxicity models (Sicot and Gomes-Pereira 2013; J. E. 
Lee and Cooper 2009). Mice models with CTG repeats in the genome displayed the 
repeat instability including expansions and contractions in both germline as well as 
somatic tissues (Monckton et al. 1997; Gourdon et al. 1997). Transgenic mice with DM1 
region of a patient inserted in its genome displayed many of the associated pathological 
features. The pathological features included myotonia, progressive weakness of skeletal 
muscles, testicular atrophy as well as cognitive dysfunction among others (Seznec et al. 
2001). In a cell culture model, expression of DMPK cDNA containing 46 CTG repeats 
 30 
 
inhibited myoblast differentiation (Usuki et al. 1997). These studies strongly suggested a 
critical role for RNA in DM1 pathogenesis. 
Stronger evidences were provided by experiments in which the CTG repeats 
were expressed independent of DMPK. In a cell culture model, expression of CTG 
repeat alone was able to inhibit myoblast differentiation (Bhagwati, Shafiq, and Xu 
1999). In another cell culture experiment, expression of DMPK 3’UTR with expanded 
repeats was able to delay myoblast differentiation and the normal DMPK 3’UTR did not 
have an effect (Amack, Paguio, and Mahadevan 1999). A transgenic mice model with 
250 CTG repeats construct inserted in the first intron of human skeletal actin (HSA-
CTG) was able to reproduce most of the disease features (Mankodi et al. 2000). Further 
evidence was provided by the identification of CCTG repeat as the disease causing 
agent in DM2.  
DM1 and DM2 have similar phenotypes, but are caused by mutations at very 
different loci in the genome suggesting an involvement of a common pathway. DMPK 
and ZNF9 have not been identified to function in the same molecular pathway. The 
mutations in both of the diseases are in the non-coding region of the transcript. Even if 
the repeats are assumed to be translated, the resulting proteins will have expansions 
containing different amino acids. Combined with the observation that expression of 
mutant RNA repeat alone in cell culture models as well as mouse models is able to 
replicate many of the clinical features of the diseases, a critical role of RNA gain of 
function seems to be beyond doubt. 
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Effects of RNA gain-of-function on splicing: The expanded CTG repeat caused a 
number of abnormalities including sequestering of RNA binding proteins in the nucleus, 
formation foci in the nucleus, changing the methylation state of the surrounding areas, 
formation of heterochromatin in the adjoining areas, decreasing transcription of the 
adjoining genes, and a decrease in the amount of DMPK protein itself. The diverse 
array of the effects of CTG expansion confounded the quest for discovery of molecular 
pathogenesis for a long time till unequivocal evidence in favor of RNA gain-of-function 
were obtained. 
 RNA gain-of-function model needs trans acting factors whose misregulation 
leads to the splicing defects observed in DM. CUG-BP1 was found to bind to CTG 
repeats in in vitro experiments with cytoplasmic and nuclear extracts (L. T. Timchenko 
et al. 1996). CUG-BP1 is a member of CELF family of proteins with six members 
(Osborne and Thornton 2006; Ranum and Cooper 2006). The EDEN-BP, a Xenopus 
homolog CELF homolog, was found to be involved in deadenylation (Paillard 1998). In 
another experiment, CUG-BP1 was found to regulate alternative translation initiation in 
in vitro experiments with mammalian cell extracts. The use of alternative initiation sites 
is one of the mechanisms to generate different isoforms of C/EBPβ transcription factor 
(N. A. Timchenko et al. 1999). CUG-BP1, another CELF family member, was found to 
modulate C to U RNA editing in mammalian cell extracts (Anant et al. 2001). In another 
study, CELF family members were found to regulate alternative splicing in cell and 
developmental stage specific manner (Ladd, Charlet-B, and Cooper 2001). In one 
study, CUG-BP2 was found to bind ARE elements in 3’ UTR of cyclooxygenase-2 
mRNA. The binding of CUG-BP2 stabilized the mRNA, but also inhibited translation (D. 
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Mukhopadhyay et al. 2003). These studies suggested that sequestration of CELF family 
proteins by the repeat containing toxic RNA could be one mechanism for DM 
pathogenesis.  
However, two very important observations contradicted the model with CELF 
family proteins at the center of DM pathogenesis mechanism. First, binding of CUG-BP 
was not found to be proportional to the CUG repeat length (Michalowski et al. 1999). 
Second, CUG-BP failed to colocalize with the nuclear RNA foci (Fardaei et al. 2001). 
This suggested that although CELF family proteins may be important in DM, they were 
not sequestered in the RNA foci and were not the primary splicing regulators important 
for pathogenesis. In a recent study, CUG-BP1 was found to be overexpressed in 
skeletal muscle biopsies of DM1 patients but not in DM2 patients (Cardani et al. 2013). 
This further ruled out CELF family proteins as the common splicing regulator affected in 
the two types of DM. 
The hunt for splicing regulator sequestered by CUG repeat containing RNAs led 
to the muscleblind-like (MBNL) family of proteins. There are three MBNL proteins in 
humans (Ranum and Cooper 2006). Muscleblind was identified in Drosophila as 
developmentally regulated gene that was important for eye and muscle development 
(Begemann et al. 1997; Artero et al. 1998). MBNL was identified as a candidate after it 
was found to bind to the larger CUG expansions in vitro. In crosslinking experiments, 
MBNL was not found to bind to RNA that had less than 11 CUG repeats (Miller 2000). 
This provided a model in which MBNL proteins were not binding to the normal repeats, 
but were only binding to the disease causing expanded repeat. 
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The expression pattern of MBNL was found to extensively overlap with the 
expression DMPK (Kanadia et al. 2003). All of the three MBNL proteins were also found 
to colocalize with the nuclear RNA foci in both DM1 and DM2 cells (Fardaei et al. 2002; 
Miller 2000; Mankodi et al. 2003). MBNL proteins were found to regulate alternative 
splicing of cardiac troponin T (cTNT) and insulin receptor (IR). Interestingly, CELF 
family proteins and MBNL promoted different splicing events in cTNT and IR suggesting 
that they have distinct roles in DM pathogenesis (Ho et al. 2004).  
MBNL sequestration can have wide ranging effects on the biology of the cells. In 
embryonic stem cells, MBNL has been found to negatively regulate expression of 
pluripotency genes. Knockdown of MBNL led to expression of pluripotency genes that 
were under control of FOXP1 transcription factor (H. Han et al. 2013). In Mbnl 
knockdown mice, fetal tau isoform expression and Mapt isoform misregulation was 
detected suggesting defects leading to mis-expression of developmentally regulated 
genes in adults. In DM1 patients there is downregulation of a chloride channel CLCN1. 
This downregulation is caused by introduction of premature stop codons in the open 
reading frame (ORF) due to splicing defects (Mankodi et al. 2002; Charlet-B. et al. 
2002; Osborne and Thornton 2006). CLCN1 had been shown to be the primary cause of 
myotonia (Koch et al. 1992). Interestingly, overexpression of CUG-BP was able to 
recapitulate the aberrant splicing defect in CLCN1 (Charlet-B. et al. 2002). Since CELF 
family proteins and MBNL proteins have opposite effects on determining the splicing 
pattern, could it be that the disruption of equilibrium between the two is the primary 
driver behind splicing defects in DM (Charlet-B. et al. 2002; Ho et al. 2004)? 
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MBNL1 has also been found to be involved in biogenesis of miR-1 in heart 
muscles from DM patients (Rau et al. 2011). In rats, miR-1 defect has been shown to be 
involved in heart development and its misregulation leads to heart conduction defect 
(Zhao et al. 2007). Regulation of miR-1 biogenesis by MBNL1 explains the heart 
conduction defects observed in DM patients. 
Transcriptomic studies in mouse models have revealed that the majority of 
defects in DM1 can be explained by the loss of MBNL1 function. In the study, mRNA 
expression of three mice strains were compared; (1) a transgenic mice expressing CUG 
repeat, (2) Mbnl knockout mice, and (3) a Clcn1 null mice (Osborne et al. 2009). In 
another study, both CUG-BP1 and MBNL1 were found to bind to the 3’UTR of target 
mRNAs and promote mRNA decay (Masuda et al. 2012). Comparison of mouse models 
expressing expanded CUG repeat containing mRNA or defective Mbnl1, revealed that 
more than 80% of the splicing defects can be explained by the loss of MBNL1 function 
(Du et al. 2010). A study in mouse and Drosophila models has revealed a global role for 
MBNL proteins in regulating the localization of mRNA (Wang et al. 2012). Taken 
together, MBNL proteins lie at the center of pathogenesis mechanism in DM. 
Differences in mechanism between DM1 and DM2: Pathogenesis mechanism in both 
DM1 and DM2 were thought to be solely mediated by RNA gain-of-function. A 
contradiction arose with studies in mouse models of DM2. In contrast to Dmpk, loss of 
function of ZNF9 led to multisystemic defects in ZNF9 heterozygous mice that was 
reminiscent of DM2 (W. Chen et al. 2007). This suggested critical role for ZNF9 protein 
in DM2 pathogenesis.  In yeast S. cerevisiae, ZNF9 was found to be a constituent of 
ITAF complex that regulates cap independent translation (Gerbasi and Link 2007). 
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Although the initial studies did not reveal a change in ZNF9 protein and mRNA levels in 
DM2 patients, many subsequent studies found a decrease in both ZNF9 protein and 
mRNA levels (Udd and Krahe 2012). In myoblasts derived form DM2 pateints, IRES 
mediated translation was found to be decreased. ZNF9 was also found to directly bind 
the IRES elements in the 5’ UTR of orinithine decarboxylase mRNA and activate cap-
independent translation (Sammons et al. 2010). 
These studies have revealed very important insights in the pathogenesis 
mechanisms of DM1 and DM2. Transcriptomic studies have shed light on the changes 
in mRNA abundances as well as RNA processing. However, the effect on the global 
proteome is poorly understood. This study is expected to shed light on the changes in 
the proteome of DM patients as well as mouse models.  
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Chapter II 
Environmental interactions and epistasis are revealed in the 
proteomic responses to complex stimuli 
Abstract 
Ultimately, the genotype of a cell and its interaction with the environment 
determine the cell’s biochemical state.  While the cell’s response to a single stimulus 
has been studied extensively, a conceptual framework to model the effect of multiple 
environmental stimuli applied concurrently is not as well developed.  In this study, we 
developed the concepts of environmental interactions and epistasis to explain the 
responses of the S. cerevisiae proteome to simultaneous environmental stimuli. We 
hypothesize that, as an abstraction, environmental stimuli can be treated as analogous 
to genetic elements. This would allow modeling of the effects of multiple stimuli using 
the concepts and tools developed for studying gene interactions. Mirroring gene 
interactions, our results show that environmental interactions play a critical role in 
determining the state of the proteome. We show that individual and complex 
environmental stimuli behave similarly to genetic elements in regulating the cellular 
responses to stimuli, including the phenomena of dominance and suppression. 
Interestingly, we observed that the effect of a stimulus on a protein is dominant over 
other stimuli if the response to the stimulus involves the protein. Using publicly available 
transcriptomic data, we find that environmental interactions and epistasis regulate 
transcriptomic responses as well.  
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Introduction 
In their native environments, cells continuously respond to a complexity of 
environmental stimuli. These include ambient temperature fluctuations, nutrient 
availability, signaling molecules, and physical forces. In response, cells adjust their 
biochemical state through multiple mechanisms including the differential production, 
modification, and degradation of transcripts and proteins (Gasch et al. 2000; Gerner et 
al. 2002; Pratt et al. 2002; Soufi et al. 2009; Yan et al. 2006). Both extracellular 
signaling and the metabolic environment strongly influence a cell’s growth and 
responses to therapeutic treatments (Whiteside 2008; Vaupel, Kallinowski, and Okunieff 
1989; Trédan et al. 2007; Hazlehurst, Landowski, and Dalton 2003). Model organisms 
have been used extensively to study cellular responses to individual and combinations 
of environmental stimuli (Gasch et al. 2000; Brauer et al. 2008; Nicola et al. 2007; 
Kanani, Dutta, and Klapa 2010; Knijnenburg et al. 2009; Knijnenburg et al. 2007; Murray 
et al. 2004; Tai et al. 2005; Vaga et al. 2014). We extend these approaches by 
developing and testing a novel conceptual framework to study proteomic responses of 
cells to the combinatorial effects of multiple concurrent environmental factors. We have 
modeled our analysis of these complex environmental interactions using the concepts of 
gene interaction and genetic epistasis. 
Gene interaction is defined as the interaction between genes at different loci that 
affect the same characteristic or a trait (Pierce 2005). Classically, genetic epistasis is 
referred to a type of gene interaction in which a mutation at one locus masks or 
suppresses the phenotype of a mutation at a different locus (Pierce 2005; Bateson 
1909). To test the independence of the effects of individual genes, genetic epistasis has 
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also been defined mathematically as a type of gene interaction in which the combined 
effect of two or more mutations is not the sum of the effects of the individual mutations 
(Cordell 2002; P. C. Phillips 2008; Fisher 1958).  
Conceptually, the problem of studying multiple concurrent environmental stimuli 
is similar to the problem of studying the effects of multiple genetic mutations. The 
product of a gene functions as part of one or more functional modules in concert with 
the products of many genes. The changes in a gene, for example its loss of function or 
gain of function, affects the phenotype due to the changes in the activity of the 
functional modules. If multiple genetic alterations are present, the total effect is due to 
the integration of the effects of the individual alterations through the functional modules. 
Similarly, environmental stimuli affect the biochemical state of the cells through specific 
sensing, signaling, and response modules. Concurrent application of multiple 
environmental stimuli, similar to the genetic alterations, requires the integration of 
information from these modules to mount an optimal response. By considering an 
environmental stimulus as an analogue of a gene, we hypothesized that the concepts of 
gene interaction and epistasis can be extrapolated to devise a conceptual framework for 
studying the combined effects of multiple concurrent stimuli.  There are several benefits 
of using this approach; (1) all the genetic, biochemical, and computational tools and 
concepts developed for studying gene interactions would become available for studying 
the effects of the environment, (2) it would allow for easier mechanistic interpretation of 
the responses to complex environmental stimuli, (3) the contributions of an individual 
stimulus to altering  biological processes can be more easily elucidated, and (4) it would 
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provide a unifying framework for studying gene-gene, gene-environment and 
environment-environment interactions.  
In this study, we define an environmental interaction as the interaction between 
different environmental stimuli that affect the same observable characteristic or trait. 
Similar to the statistical definition of genetic epistasis, environmental epistasis is an 
environmental interaction in which the effects of the individual stimuli are not 
independent of each other (Cordell 2002; Fisher 1958; P. C. Phillips 2008).   To test our 
hypothesis, we used the yeast S. cerevisiae and grew cells at standard conditions 
(glucose, 30oC) and changed growth conditions  to either high temperature (37oC, HT 
stimulus) or the non-fermentable carbon source glycerol (G stimulus) and concurrently 
with both environmental stimuli (glycerol, 37oC, HT+G stimuli) (Figure 2).  Using precise 
quantitative proteomics of the S. cerevisiae proteome and the changes in protein 
abundance as the readouts of the interactions, we show that environmental interactions 
and epistasis play central roles in determining the state of the proteome in response to 
multiple, concurrent environmental stimuli. We also show that, using the dominance of 
one stimulus over another, environmental interactions can be used to identify proteins 
that are important for responding to a dominant stimulus. We validated our approach 
using an independent publicly available transcriptomic dataset.  
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Figure 2 - Experiment design to study environmental interactions and epistasis. 
Experimental design workflow used in this study. Two environmental stimuli used were high temperature 
and glycerol as the carbon source. Diploid S. cerevisiae cells (BY4743) were grown in rich media under 4 
conditions: 1) glucose at 30oC (used as control), 2) glycerol at 30oC (G stimulus), 3) glucose at 37oC (HT 
stimulus), and 4) glycerol at 37oC (HT+G stimuli).  Three biological replicates were performed for each 
condition. 
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Materials and Methods 
Strains and Media.  All experiments used the diploid S. cerevisiae strain BY4743, 
which has been previously described (Baker Brachmann et al. 1998). Cells were grown 
using standard techniques (Amberg, Burke, and Strathern 2005).  
Growth rate analysis. Cells were grown in 96 well plates in 100 μL cultures (10 μL of 
starter culture and 90 μL of fresh media) with continuous shaking in a BioTek Synergy™ 
4 Hybrid Microplate Reader for 10 h. Growth rates were assayed at 8 conditions: (1) 
Synthetic complete medium with glucose (ScD) at 30oC, (2) ScD at 37oC, (3) Synthetic 
complete medium with glycerol (ScG) at 30oC, (4) ScG at 37oC, (5) Yeast extract, 
peptone medium with glucose (YPD) at 30oC, (6) YPD at 37oC, (7) Yeast extract, 
peptone medium with glycerol (YPG) at 30oC, and (8) YPG at 37oC. Absorbance was 
measured at 660nm at 3 min intervals. Using custom R scripts, the doubling times were 
calculated from the linear regression curve through the log growth phase using the log 
of the absorbance and time of growth. A two-tailed t-test of independence with 
Bonferroni correction for the 11 comparisons (7 comparisons of the control, YPD at 
30oC, to the test conditions, 3 comparisons of the observed concurrent double stimuli 
effect to the expected sum of individual stimulus effects, and 1 comparison of the 
observed concurrent three stimuli effect to the expected sum of the effects of the three 
individual stimulus) was used to calculate the statistical significance of a stimulus effect 
on the growth rate (Dunn 1961).  
Preparation of yeast protein extracts: Five mL of YPD (1% yeast extract, 2% 
peptone, 2 % glucose) was inoculated with a single yeast colony from a YPD agar plate 
and grown overnight.  Three replicates were grown under each growth condition: YPD 
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at 30°C and 37°C and YPG at 30°C and 37°C.  50 mL of YPD was inoculated with 50 
µL of the overnight culture and grown at 30°C and 37°C.  100 mL of YPG (1% yeast 
extract, 2% peptone, and 3% glycerol v/v) was inoculated with overnight cultures and 
grown at 30°C and 37°C. The cultures were grown with constant shaking at 175 rpm in 
Innova 44 shaker incubators (New Brunswick Scientific). For all four growth conditions, 
cells were harvested at mid-log phase as determined by OD600 measurements.  Cells 
grown in YPD were harvested after 14 h, while cells grown in YPG were harvested after 
24 h. All cultures were centrifuged at 2000 rpm for 5 min at 4°C using a Sorvall 
HLR6/H600A/HBB6 rotor in Sorvall RC-3B centrifuge and washed with ice cold 
deionized H20.  The cell pellets were resuspended in 1 mL ice cold wash buffer (10 mM 
Tris pH 8.0, 5 mM beta-mercaptoethanol, 500 mM ammonium chloride, 100 mM 
magnesium acetate) and lysed at 4°C using glass beads and a Bead Beater (BioSpec, 
Inc) for 10 min as previously described (Browne et al. 2013).  The whole cell extracts 
(WCE) were clarified by centrifugation at 20,000g for 15 min at 4°C, and a 200 μL 
aliquot of the cleared WCE was stored at -80 °C.   
iTRAQ labeling: The total protein concentration was determined using a Bradford 
assay according to the manufacturer’s protocol (Sigma Aldrich).  For each growth 
condition, 50 μg of total protein was mixed with 50 ng of bovine serum albumin (Thermo 
Scientific) as an internal standard.  Each protein sample was acetone precipitated and 
resolublized in 25 µl iTRAQ dissolution buffer (500 mM triethylammonium bicarbonate, 
0.1% sodium dodecyl sulfate).  The proteins were reduced with tris(2-
carboxyethyl)phosphine at 60°C for 60 min and the cysteines were derivatized with 
methyl methanethiosulfonate at room temperature for 10 min.  All samples were 
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digested with sequencing-grade modified trypsin (1:50; Promega Corporation) overnight 
at 37°C.  Equal fractions of the tryptic digests from the three replicates grown in YPD at 
30°C were pooled separately and used as a control for the iTRAQ experiments.   Fifty 
μg of the pooled control and 50 μg of each of the replicates were used for iTRAQ 
labeling. The iTRAQ labeling reagents were resolublized in 150 μL anhydrous ethanol 
(Sigma Aldrich). 75 μL of iTRAQ reagent solutions were added to each 50 μg sample, 
incubated with shaking for 1 h at room temperature on an Eppendorf Thermomixer R, 
pooled, frozen, lyophilized, resolublized in 200 μL of buffer A (0.1 % formic acid), and 
stored at -80°C. 
Liquid chromatography and mass spectrometry:  The iTRAQ-labeled samples were 
analyzed with MudPIT as previously described (Hoek et al. 2015). Briefly, 11 fractions 
corresponding to ammonium acetate pulses of 25mM, 50mM, 75mM, 100mM, 150mM, 
200mM, 250mM, 300mM, 500mM, 750mM, and 1M concentrations were analyzed on 2 
hour reverse phase gradients. Precursor ions were analyzed in the Orbitrap mass 
analyzer followed by four CID fragment ion scans in the ion trap and four HCD fragment 
ion scans (normalized collision energy  = 45%) in the Orbitrap. Dynamic exclusion was 
enabled with exclusion window of 180 seconds. Monoisotopic precursor selection was 
enabled. 
iTRAQ data analysis: RAW files generated by the MudPIT experiments were searched 
using the Sequest HT database search engine  running under Proteome Discoverer 
v1.4 (Thermo Scientific) against a forward and reverse yeast protein database 
(S.cererevisiae_orf_trans_all_SGD.fasta.6718) with appended common contaminant 
sequences (Eng et al. 2008; Eng, McCormack, and Yates 1994). The CID and HCD 
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spectra were merged using the Spectrum Grouper function in Proteome Discoverer by 
setting the retention time window to 0.05 minutes and precursor mass tolerance to 
10ppm. Beta-methylthiolation of cysteines, and iTRAQ modification of lysine and N-
terminus were included as constant modifications. Oxidation of methionine and 
tryptophan, and deamidation of glutamine and asparagine were used as variable 
modifications. Precursor mass tolerance was set to 3 Da and fragment mass tolerance 
was set to 0.8 Da. Protein assembly, reporter ion quantitation, and protein fold change 
calculations were done using ProteoIQ at 5% peptide and protein FDR (Premier 
Biosoft). Hierarchical clustering analysis was done using Cluster 3.0 (Eisen et al. 1998). 
Heatmaps were generated using Java Treeview (Saldanha 2004).  Circos plots were 
generated as described in Krzywinski et. al. to visualize the genomic locations of the 
quantitated proteins (Krzywinski et al. 2009).  For better visualization, only those regions 
of the genome that were quantitated in this study are shown.  
Environmental interaction analysis: All analyses were performed using R scripts to 
parse the fold change expression data to identify proteins that show specific expression 
patterns in response to complex environmental stimuli. For each protein, we used linear 
regression to test for any association of high temperature or glycerol using a model that 
included main effects for glycerol and temperature and the glycerol by temperature 
interaction. We used the effect size estimates and ANOVA p-values (3 df) calculated by 
the lm function and adjusted the p-values for a 5% FDR using the Benjamini-Hochberg 
procedure for finding differentially expressed proteins  (Benjamini and Hochberg 1995). 
We used the adjusted p-value cut-off of 0.05 to determine statistical significance. If the 
overall adjusted p-value was greater than 0.05, we classified the proteins as non-
 45 
 
responders. The positive and negative signs of the effect size estimates correspond to 
upregulation and downregulation, respectively, showing the direction of change.  The 
remaining proteins were further classified into environmental interaction classes based 
upon the effect size estimate p-values and the direction of change. If the p-value of an 
estimate was less than 0.05, the protein was considered differentially expressed in 
response to that environmental stimulus.  
To test if a protein is affected by environmental epistasis, the effect size 
estimates for the individual high temperature (HT) and glycerol stimuli (G) were 
summed, the combined standard error calculated as the square root of the sum of the 
squared standard errors, and a two-sample t-test of independence was used to 
compare the summed effect size estimate to the effect size estimate for the concurrent 
high temperature and glycerol stimuli (HT+G). If a t-test p-value was less than 0.05, the 
protein was assumed to be affected by environmental epistasis. 
Environmental interaction analysis of transcriptomic dataset: Normalized 
expression data described in Knijnenburg et. al. was downloaded (Knijnenburg et al. 
2009). The transcriptomic data were generated using haploid S. cerevisiae 
(CEN.PK113-7D MATa) cells grown in chemostat cultures (Knijnenburg et al. 2009). We 
chose 4 culture conditions similar to our experimental design for further analysis. The 
culture conditions tested were: 1) with ammonium sulfate as the nitrogen source (n=5), 
2) with methionine as the nitrogen source (n=3), 3) anaerobic conditions (n=4), and 4) 
with methionine as the nitrogen source and anaerobic conditions concurrently (n=3).  
Transcriptomic data from the cells grown with ammonium sulfate as the nitrogen source 
were used as the baseline control. The fold change was calculated by subtracting the 
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average normalized expression data of baseline samples from the individual expression 
data. Finally, the genes were classified into various types of environmental interaction 
as described above. 
Co-expression network analysis: Sparse PArtial Correlation Estimation (SPACE) was 
used to build protein co-expression networks and identify the hub genes (Peng et al. 
2009). To account for outliers, the data were normalized using probabilistic quotient 
normalization and scaled using a generalized logarithmic scaling factor (Dieterle et al. 
2006; Durbin et al. 2002). The data were scaled and centered to have a standard 
deviation of 1 and mean of 0 to remove any bias in the correlation analysis (Berg et al. 
2006). We estimated the partial correlation matrix using the space.dew method 
implemented in the SPACE R package (Peng et al. 2009).  We selected the default 
value of the tuning parameter for constructing the initial network (Peng et al. 2009). The 
network was visualized in Cytoscape 3.1.1 (Shannon et al. 2003). 
Results 
While cells measure and respond to many environmental stimuli, we chose 
temperature and carbon source to test our hypothesis. Both stimuli are known to be 
important factors for survival and have wide-ranging effects on yeast metabolism 
(Gasch et al. 2000).  We used growth with glucose at 30°C as the control, and high 
temperature and glycerol as the stimuli. The changing growth conditions were:  glucose 
at 37°C (HT stimulus), glycerol at 30°C (G stimulus), and glycerol at 37°C concurrently 
(HT+G stimulus).  To precisely measure the proteomic responses of the cell, we used 
isobaric tag for relative and absolute quantitation (iTRAQ) labeling followed by multi-
dimensional protein identification technology (MudPIT)-based mass spectrometry to 
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quantify the steady state proteomes under the four different growth conditions (Link et 
al. 1999; Ross et al. 2004).  A total of 1064 proteins were quantitated in the control and 
the three test conditions. We filtered the data to focus only on the 466 proteins that were 
quantitated in all three independent replicates of all of the three test conditions (Fig. 3A).   
 
Figure 3 - Proteomic responses to complex environmental stimuli. 
Diploid S. cerevisiae (BY4743) cells were grown in rich media under 4 conditions: 1) glucose as the 
carbon source at 30oC, 2) glycerol as the carbon source at 30oC, 3) glucose at 37oC, and 4) glycerol at 
37oC.  Three biological replicates for each growth conditions were performed. Fold changes were 
calculated from iTRAQ reporter ion intensities using reporter ion intensities from the pooled replicates of 
growth in glucose as the carbon source at 30oC as the baseline. The fold changes were log2 transformed 
for downstream analysis. The color bar shows the fold change ranges. A) Complete filtered proteomic 
dataset for high temperature stimulus (HT), glycerol stimulus (G), and concurrent glycerol and high 
temperature stimuli (HT+G) (Red: Up, Green: Down, Black: No change). The heatmap represents the fold 
changes of 466 proteins. B) Fold changes of 283 proteins differentially expressed in response to HT 
stimulus. C) Bar graph shows the –log q-value of enrichments of the top 5 pathways in the list of proteins 
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differentially expressed after the HT stimulus. D) Fold changes of 379 proteins differentially expressed in 
response to the G stimulus. E) Bar graph shows the –log q-value of enrichments of the top 5 pathways in 
the list of proteins differentially expressed after the G stimulus. 
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Figure 4 - Correlation matrix heatmap 
Correlation matrix was generated in R. There is a high correlation among replicates showing 
reproducibility across experimental replicates (red is high). 
Cross-correlation analysis of the filtered data showed high reproducibility among 
the replicates (Figure 4). The proteomic changes in the cells grown with the concurrent 
stimuli were more similar to the changes induced by glycerol compared to high 
temperature (Figure 4).  
We defined the response to an environmental factor(s) as the log2-fold change in 
protein abundance/expression between the control and experimental conditions.  For 
this study, we use “fold change” to denote the log2 fold change.  We built linear 
regression models for each protein using fold changes to estimate the effect sizes of the 
stimuli. We used ANOVA for estimating statistical significances since we were 
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comparing multiple stimuli. We interpreted the positive or negative sign of the effect size 
as either upregulation or downregulation, respectively.  The Benjamini-Hochberg 
procedure was used to adjust the ANOVA p-values at 5% FDR (Benjamini and 
Hochberg 1995). A protein was assumed to be differentially expressed if the adjusted 
overall ANOVA p-value was less than 0.05. These proteins were further analyzed and 
classified into different environmental interaction classes using the direction of the 
change (upregulated or downregulated) and the p-values of the effect size estimates 
(Benjamini and Hochberg 1995).  
Stimuli-specific expression patterns can be used to identify proteins important 
for responding to the stimuli. 
We observed 283 proteins differentially expressed with high temperature, 379 
proteins differentially expressed in response to glycerol, and 370 proteins were 
differentially expressed in concurrent high temperature and glycerol (Fig. 3B and D, and 
Table 1), while 41 proteins did not change in response to any of the stimuli. We selected 
GeneMANIA Cytoscape plugin for pathway analysis since it extends the input list of 
differentially expressed proteins by adding related proteins to enhance sensitivity and 
coverage (Montojo et al. 2010; Mostafavi et al. 2008). It also allows using the complete 
proteome as the background. This helped to build a more complete picture of 
differentially regulated pathways. Pathway analysis of these two differentially expressed 
protein groups revealed the same top five pathways; none were specific to either 
stimulus (Fig. 3C and E). All of the top five pathways were related to protein synthesis 
and translational control, suggesting that the regulation of protein synthesis is an 
important step in responding to environmental stimuli. Translation factors are some of 
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the most abundant proteins in yeast and our proteomic assays are limited by the 
abundance of proteins in the cell. Although this could have confounded pathway 
analysis and led to the identification of translation associated pathways as being the 
most enriched, using only the differentially expressed proteins suggests that these 
pathways are, at the least, being differentially regulated. Furthermore, similar 
observations have also been made in previous studies (Gasch et al. 2000; Brauer et al. 
2008; Roberts and Hudson 2006). It is noteworthy that the pathways expected to be 
important for responding to these stimuli, such as “protein folding” for growth at high 
temperature and “TCA cycle” for growth with glycerol  were present farther down the list 
at numbers 39 and 53, respectively (Tables 2 and 3) (Richter, Haslbeck, and Buchner 
2010; Riezman 2004; Schüller 2003). This mirrors a common problem in ‘omics’ studies 
that generate large lists of candidate genes, transcripts and proteins. The important 
responders are lost in a long list where a majority of differentially expressed genes or 
proteins is not directly responding to the stimulus. Therefore, choosing candidates for 
an in-depth mechanistic study becomes a challenge.  
To address this problem, we devised a methodology using dominance in 
environmental interactions to identify proteins and pathways important for responding to 
a stimulus.  We noticed proteomic expression patterns in which the response to one 
stimulus was dominant over the other. We speculated that a protein critical in 
responding to a stimulus will respond to that stimulus even when challenged by a 
competing stimulus. If this hypothesis is correct, such an environmental interaction 
could serve as a filter to select and identify proteins that respond specifically to the 
dominant environmental stimulus.  
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To test this hypothesis, we classified the list of 466 proteins responding to the 
concurrent glycerol and high temperature stimuli based upon their expression patterns. 
Two classes of dominant environmental interactions are possible.  In one class, a 
stimulus reverses an expression change induced by the other stimulus (Fig5A and B, 
top panels, rows 1 and 3). In the other class, a stimulus induces a change in 
expression, while the other stimulus has no effect on its own and does not change the 
response to the concurrent stimulus (Fig. 5A and B top panels, rows 2 and 4). Each 
class is represented by two theoretical expression patterns for a total of four expression 
patterns for each stimulus (Fig. 5A and B top panels). 
 
Figure 5 - Dominance of an environmental stimulus used to identify proteins that are important for 
responding to the environmental stimulus 
The color bar shows the range of fold changes.  Pathway analysis was done using the GeneMANIA 
Cytoscape plugin. Bar graphs were generated in Graphpad Prism. A) Proteins for which HT stimulus is 
 53 
 
dominant over G stimulus.  The theoretical expression patterns are depicted in the top panel (Red, 
upregulation; green, downregulation; and black no statistically significant change in expression). The 
heatmap of fold changes in expression for 30 proteins for which HT stimulus is dominant over G stimulus 
is shown in bottom panel.  B) Proteins for which G stimulus is dominant over HT stimulus.  The theoretical 
expression patterns are depicted in the top panel. The heatmap of fold changes in expressions for 121 
proteins for which G stimulus is dominant over HT stimulus is shown in bottom panel.  C) Bar graph 
shows the –log q-value of enrichments of the top five pathways in the list of proteins for which HT 
stimulus is dominant over G stimulus. D) Bar graph shows the –log q-value of enrichments of the top five 
pathways in the list of proteins for which G stimulus is dominant over HT stimulus. 
For the environmental interactions in which the HT stimulus was dominant over 
the G stimulus, the p-values for all of the effect size estimates were less than 0.05. The 
changes for the HT and HT+G stimuli were in the same direction and differed from the 
G stimulus (Fig. 5A, top panel, rows 1 and 3). Alternatively, the p-values for only the HT 
and HT+G stimuli effect size estimates were less than 0.05 and the directions of change 
for the HT and HT+G stimuli were the same (Fig. 5A, top panel, rows 2 and 4). In all, we 
identified 30 proteins for which the response to the HT stimulus was dominant over the 
G stimulus (Fig. 5A and Table 1). We used pathway analysis to identify which protein 
classes were responding to the dominant stimulus.  The group of proteins for which the 
HT stimulus was dominant included the heat shock response proteins HSP10, HSP60, 
SSA1, SSA2, and HSP150 (Fig. 5A bottom panel, and Table 1). Pathway analysis of 
these 30 proteins showed that the top five enriched pathways included protein folding, 
protein refolding, and unfolded protein binding (Fig. 5C, Table 5). These pathways are 
expected to be important for growth at higher temperatures (Richter, Haslbeck, and 
Buchner 2010; Riezman 2004; Åkerfelt, Morimoto, and Sistonen 2010; de Nadal, 
Ammerer, and Posas 2011). 
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For the environmental interaction in which the G stimulus is dominant, we saw a 
similar set of patterns as described above except the G stimulus dominates the HT 
stimulus (Fig. 5B, top panel). There are 121 proteins for which the response to the G 
stimulus was dominant over the HT stimulus (Fig. 5B, bottom panel and Table 1).  The 
group of proteins for which the G stimulus was dominant includes metabolic enzymes 
such as CDC19, ACO1, and LSC1 (Fig. 5B, bottom panel, and Table 1).  Pathway 
analysis of these 121 proteins showed that the top five pathways included the oxidation-
reduction process, the generation of precursor metabolites and energy, and the 
tricarboxylic acid cycle (Fig. 5D, and Table 6). All of these three pathways are expected 
to be important for respiratory growth (Schüller 2003; Brisson et al. 2001; Nevoigt and 
Stahl 1997).  Consistent with our hypothesis, pathway analysis of proteins that respond 
to a dominant environmental stimulus reveals a functional relationship to the response 
to the stimulus.  High temperature has a dominant effect on proteins involved in protein 
folding, while glycerol has a dominant effect on proteins involved in respiratory 
metabolism. These results show the practical applications of using dominant 
environmental interactions to identify proteins that respond to specific stimuli and that 
are directly involved in the cell’s response to that stimulus.  
Analysis of expression patterns reveals that environmental interactions mirror 
gene interactions. 
In addition to the dominant interactions of concurrent environmental stimuli, we 
observed other classes of environmental interactions that mirror gene interactions.  
First, we observed a class of proteins whose abundance either increased or decreased 
in response to both the individual stimuli as well as the concurrent stimuli (Fig. 6A). This 
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is similar to gene pairs in which both the individual mutants as well as the double mutant 
have the same phenotype.  We classified these proteins as non-specific environmental 
responders. This class is represented by two theoretical expression patterns:  activated 
or repressed (Fig. 6A, top panel and Table 1). For these non-specific environmental 
response modules, the p-values for all the effect size estimates were less than 0.05 and 
the directions of change were the same (Fig. 5A, top panel). We identified 175 proteins 
that correspond to these patterns, and pathway analysis revealed that they are largely 
involved in protein synthesis and translational control (Fig. 5A, bottom panel and 5D, 
and Table 7).  
We also observed proteomic responses to concurrent environmental stimuli 
similar to gene interactions in which the two single mutants are wild-type or have one 
phenotype, while the double mutant has a different phenotype (Fig. 6B).  This class 
includes proteins whose expression was either decreased or unchanged after a single 
stimulus but was increased if both stimuli were applied concurrently.  The class also 
includes proteins whose expression was either increased or unchanged after a single 
stimulus but was decreased by the concurrent stimuli. We classified this environmental 
interaction group as a discordant class. There are eight theoretical expression profiles in 
the discordant environmental interaction class (Fig. 6B, top panel). For the discordant 
environmental interaction, the p-value for the HT+G concurrent stimuli effect size 
estimate was less than 0.05 and the directions of change for either the HT or G stimuli 
were not the same as HT+G. We identified 41 proteins that show discordance (Fig. 6B, 
bottom panel and Table 1).  They are mainly involved in protein synthesis and metabolic 
pathways (Fig. 6E, and Table 8).   
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Figure 6 - Proteins in different environmental interaction classes and the corresponding enriched 
pathways after concurrent G and HT stimuli 
The color bar shows the range of fold changes. Pathway analysis was done using GeneMANIA 
Cytoscape plugin. Bar graphs were generated in Graphpad Prism. A) Non-specific environmental 
response (NER) proteins to individual and concurrent HT and G environmental stimuli. The theoretical 
expression patterns are shown in the top panel. The fold changes of 175 NER proteins are shown as a 
heatmap. B) The theoretical expression patterns for discordant environmental interaction are shown in the 
top panel. The fold changes of 41 proteins are shown as a heatmap. C) The theoretical expression 
patterns for suppression environmental interaction are shown in the top panel. The fold changes of the 58 
proteins affected by suppression are shown as a heatmap. D) Bar graph shows the –log q-value of 
enrichments for the top 5 pathways for the non-specific environmental response proteins. E) Bar graph 
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shows the –log q-value of enrichments for the top 5 pathways in the list of proteins affected by discordant 
environmental interaction. F) Bar graph shows the –log q-value of enrichments for the top 5 pathways in 
the list of proteins affected by suppression environmental interaction. 
Finally, we observed suppression, in which a protein’s abundance changed in 
response to a single stimulus, yet the change was suppressed by the simultaneous 
application of the second stimulus (Fig. 6C).  This class is similar to gene interactions in 
which double mutants show the wild-type phenotype (Dixon et al. 2009; St Johnston 
2002). The suppression class is represented by eight theoretical expression patterns 
(Fig. 3C, top panel).  For suppression environmental interactions, the p-value for the 
HT+G effect size estimate was more than 0.05, and the p-value for at least one of HT 
and G stimuli effect size estimates was less than 0.05. We identified 58 proteins that are 
affected by suppression (Fig. 6C, bottom panel and Table 1). Pathway analysis 
revealed that metabolic pathways are most affected by suppression (Fig. 6F and Table 
9).  
A large fraction of the proteome is affected by environmental epistasis. 
An important feature of genetic epistasis is that the modulating effects of multiple 
genes are not always independent of each other (Cordell 2002; P. C. Phillips 2008; 
Fisher 1958; Visser, Cooper, and Elena 2011; Mani et al. 2008).  In many cases, non-
independence is diagnostic of a functional relationship between genes (Cordell 2002; P. 
C. Phillips 1998; Visser, Cooper, and Elena 2011).  Genetic epistasis is used to test if 
the effects of genetic elements are independent. Genetic epistasis occurs when the 
effects are not independent.  We tested if the effects of these two individual 
environmental stimuli were independent of each other for individual proteins in the 
 58 
 
proteome. Similar to the mathematical approach to genetic epistasis, we measured the 
response of each protein and classified a response as influenced by environmental 
epistasis if the sum of the effects of the individual stimuli for a protein was not equal to 
the response to the concurrent stimuli (t-test, p-value ≤0.05) (Cordell 2002; Fisher 1958; 
P. C. Phillips 2008).  We used log2 fold change as the measure of the effect of a 
stimulus. From our list of 466 quantitated proteins, 240 proteins were affected by 
environmental epistasis (Table 1). Pathway analysis of these proteins revealed that a 
majority of the enriched pathways are involved in protein synthesis and translation 
control (Fig. 7A and Table 10). The topmost enriched pathways included cytoplasmic 
translation, cytosolic ribosome, and structural constituent of ribosome (Fig. 7A and 
Table 11).  
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Figure 7 -  Environmental epistasis in the proteomic response to concurrent stimuli 
Pathway analysis was done using the GeneMANIA Cytoscape plugin. Bar graphs were generated in 
Graphpad Prism.  A) Bar graph shows the –log q-value of enrichments of the top 10 pathways in the list 
of proteins affected by epistasis (purple) and their –log q-value in the list of proteins not affected by 
epistasis (orange). B) Bar graph shows the–log q-value of enrichments of the top 10 pathways in the list 
of proteins not affected by epistasis (orange) and their –log q-value in the list of proteins affected by 
epistasis (purple). 
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Pathway analysis of the 226 proteins not affected by environmental epistasis 
revealed a large number of metabolic pathways (Fig. 7B and Tables 1 and 10). It is 
interesting to note that the distribution of pathways affected by environmental epistasis 
is different from those that are unaffected. Protein synthesis and translational control 
seems to be disproportionately affected by environmental epistasis compared to other 
pathways. These pathways have previously been found to change in response to the 
changes in the growth rate (Regenberg et al. 2006; Slavov and Botstein 2011). If the 
effects of the two stimuli on the growth rate are not independent, it could explain the 
observed environmental epistasis. To test the independence in the effects of the two 
stimuli on the growth rate, we determined the doubling times under the same conditions. 
The change in the doubling times was used to measure the effect of a stimulus. Our 
data shows that the effects of high temperature and glycerol on the growth rate are 
additive and, therefore, independent of each other (Fig. 8). Further studies are required 
to elucidate the functional significance of the environmental epistasis. 
A number of genetic epistasis subtypes have been defined based upon the 
mathematical models used to measure the expectation of a phenotype in double 
mutants (Visser, Cooper, and Elena 2011; Mani et al. 2008; Gao, Granka, and Feldman 
2010; Hallgrímsdóttir and Yuster 2008; Li and Reich 2000). Four most commonly used 
definitions are (1) additive, (2) multiplicative, (3) minimum, and (4) log (Mani et al. 2008; 
Gao, Granka, and Feldman 2010).  Although we used only the additive definition for 
developing the concept of the environmental epistasis in this study, future studies can 
be performed to compare the results obtained using different definitions.  
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Figure 8 - The effect of high temperature and glycerol on yeast doubling times 
Doubling times were calculated for growth in control (n=25), high temperature (n=25), glycerol (n=25), 
and concurrent high temperature and glycerol (n=24). The difference in doubling times from the control 
was used to measure the effect of the stimuli and is plotted on Y-axis. HT leads to a decrease of  -11 
minutes (sd = 6), G leads to an increase of 137 minutes (sd = 14), and HT+G leads to an increase of 142. 
minutes (sd = 22). The expected effect of HT+G was calculated by summing the observed effects of HT 
and G (Sum HT+G, increase of 127 minutes with sd of 16). The difference in the means for HT+G and 
Sum HT+G was not statistically significant (p-value = 0.1034, two-tailed t-test of independence with 
Bonferroni correction for 11 comparisons) 
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Environmental interactions and epistasis regulate mRNA levels. 
Although, we identified the environmental interactions using quantitative 
proteomic data, we speculated that this framework would be applicable to any 
quantifiable readout including transcriptomic and phenotypic traits. In pioneering studies 
using chemostat cultures of S. cerevisiae, Knijnenburg et al. measured the 
transcriptional response of yeast to multiple, concurrent environmental stimuli 
(Knijnenburg et al. 2009).  They found linear regression models of expression for the 
vast majority of genes required a combinatorial interaction term (Knijnenburg et al. 
2009). This suggests the change in transcription of most genes cannot be explained by 
simply adding the effects of the individual stimuli.  Based on our proteomic results, we 
hypothesized that environmental epistasis plays a role in determining the state of the 
transcriptome as well. 
  To test if our environmental interaction and epistasis models are observed in the 
transcriptomic responses to concurrent stimuli, we analyzed Knijnenburg dataset which 
measured the transcriptomic responses of yeast cells growing in carbon limited 
chemostat cultures (Knijnenburg et al. 2009).  In the experiment, two concurrent stimuli 
were applied: (1) a change in nitrogen source from ammonium sulfate to methionine 
and (2) a change from aerobic to anaerobic growth (Fig. 9A and Table 12) (Knijnenburg 
et al. 2009). The data showed 564 transcripts were affected by environmental epistasis, 
while 5987 transcripts were not affected (p-value ≤0.05) (Table 12).  In contrast to our 
proteomic analysis, pathway analysis of the transcripts affected by environmental 
epistasis revealed enrichment for pathways including microbody, peroxisome, and 
phytosteroid metabolic process (Table 13). This could be because of the differences 
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between the strains, stimuli, and culture conditions used in the transcriptomic and our 
proteomic studies. Similar to our proteomic analysis, we observed dominant 
environmental interactions in the expression of the transcripts (Fig. 9B and 9C and 
Table 12).  Nitrogen source was dominant for 281 transcripts (Fig. 9B and Table 12).  
Pathway analysis of these transcripts identified pathways involved in methionine 
metabolism such as sulfur amino acid metabolic process, sulfur compound metabolic 
process and methionine metabolic process (Fig. 9D and Table 14).  Similarly, anaerobic 
growth was dominant for 938 transcripts (Fig. 9C and Table 12). Pathway analysis of 
these differentially expressed transcripts showed enrichment of pathways involved in 
energy production such as cellular respiration, mitochondrial membrane and respiratory 
chain (Fig. 9E and Table 15).  We also observed the same environmental interaction 
classes in their transcriptomic data as in our proteomic data, including non-specific 
environmental response, discordance, and suppression (Table 12). These results 
strongly suggest that environmental interactions play a significant role in regulating the 
biochemical state of cells. 
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Figure 9 - Environmental interactions affect transcriptomic profiles as well 
Normalized expression data from Knijnenburg et. al. 2009 was used for the analyses. The transcriptomic 
data used in the study used haploid S. cerevisiae cells (CEN.PK113-7D MATa) grown in carbon limited 
chemostat cultures under 4 conditions – 1) ammonium sulfate as nitrogen source  (n=5), 2) methionine as 
nitrogen source, NS stimulus (n=3), 3) Anaerobic condition, AN stimulus (n=4), and  4) methionine as 
nitrogen source under anaerobic conditions NS+AN stimulus (n=3) (13).  Fold changes were calculated 
from normalized expression data using average normalized expression data from the five replicates of 
growth with ammonium sulfate as the baseline. The color bar shows the range of fold changes. Pathway 
analysis was done using GeneMANIA Cytoscape plugin. Bar graphs were generated in Graphpad Prism. 
A) A heatmap of fold changes of the complete transcriptomics dataset consisting of 6551 transcripts. B) A 
heatmap showing the fold changes for 281 transcripts for which NS stimulus is dominant. C) The –log q-
value of enrichment for the top 5 pathways enriched in the list of transcripts for which NS stimulus is 
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dominant. As anticipated, pathways expected to be involved in metabolization of methionine are enriched. 
D) A heatmap showing the fold changes for 938 transcripts for which AN stimulus is dominant. E) The –
log q-value of enrichment for the top 5 pathways enriched in the list of transcripts for which AN stimulus is 
dominant. As anticipated, pathways expected to be involved in energy production are enriched. 
Coexpression network analysis shows community structures are guided by 
environmental interaction and epistasis. 
 Coexpression networks link together proteins whose expression levels are 
regulated in the same way (Stuart et al. 2003; B. Zhang and Horvath 2005).   As a 
consequence, coexpression network analysis can be used to determine if the 
abundances of proteins affected by environmental epistasis are regulated differently 
than the proteins that are not affected by environmental epistasis. To explore the protein 
modules whose expression changes are correlated with each other, we built a 
coexpression network using the merged proteomic responses from both individual and 
concurrent stimuli using the Sparse PArtial Correlation Estimation approach (SPACE) 
(Fig. 2A) (Peng et al. 2009). An edge, representing coexpression, was introduced 
between two proteins if the correlation between them was above the average of the 
correlation matrix.  To validate the network, we first tested the power law structure of the 
reconstructed network (Peng et al. 2009; Clauset, Shalizi, and Newman 2009). The 
reconstructed network followed the power law distribution. The power law parameter α 
was approximately 4, which is close to the empirically observed value of 3.45 (Clauset, 
Shalizi, and Newman 2009).  
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Figure 10 - Coexpression network based on all the quantified proteins and all conditions 
Proteins are depicted as nodes. Nodes that are coexpressed are connected with an edge. The 
coexpression network was generated with SPACE algorithm using fold change. Network visualization and 
analysis was done in Cytoscape 3.1.1. Bar graphs were generated in Graphpad prism. A) All nodes that 
have at least one edge. Nodes affected by environmental epistasis are highlighted in purple. The circular 
layout was used to generate the initial network graphics in Cytoscape 3.1.1. Far-flung communities of 
inter-connected nodes were manually brought together, while preserving the inner community structure, 
for better visualization. B) The largest community in the coexpression network. Most of the proteins 
affected by environmental epistasis are members of a subgraph (top circle) that predominantly contains 
A B 
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other proteins that are also affected by environmental epistasis. A similar trend is observed with the 
proteins not affected by environmental epistasis (bottom circle). C) The numbers of three types edges: 1) 
both nodes are affected by environmental epistasis (199 edges), 2) neither of the nodes are affected by 
environmental epistasis (85 edges), and 3) only one of the nodes is affected by environmental epistasis 
(75 edges). Proteins affected by epistasis are predominantly connected to proteins that are also affected 
by epistasis. D) Number of edges that connect nodes to other nodes within the same environmental 
interaction classes (299) or between the classes (60). Co-regulatory connections between proteins are 
predominantly between those of the same class. 
Next, we repeatedly reconstructed the network by varying the tuning parameter 
around the default value and fitting the network to the power law distribution. We found 
that the reconstructed network follows the power law distribution and that the power law 
parameter was in the range of 3.75. We identified the sub-graph spanned by the top 1% 
of highly connected nodes. We found that the Jaccard similarity score of these highly 
connected nodes was 0.83 on the scale of 0 to 1.  Therefore, these nodes were 
classified as hub nodes, which is one of the characteristic features of power law 
networks. There were 7 hub nodes based upon the above criterion.  Next, we checked 
the significance of the identified hubs using the Wilcox Rank sum test and found that the 
hub community is statistically significant (p-value = 0.04) (Kolaczyk and Csárdi 2014). 
Finally, we compared the reconstructed network with BioGrid protein interaction data 
and found that approximately 30% of the edges are previously known interactions and 
that these interactions were found in every reconstructed network when we varied the 
tuning parameter to estimate the partial correlation matrix (Stark et al. 2006). The final 
coexpression network consisted of 329 nodes with at least one neighbor and a total of 
359 edges (Fig. 10A).   
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The largest community within this network includes 205 nodes and 249 edges, 
with two clearly separate sub-graphs connected by a single node (Fig. 10B). 
Interestingly, one sub-graph consists predominantly of proteins affected by 
environmental epistasis while the second sub-graph consists of proteins not affected by 
environmental epistasis. Within the global coexpression network, we observed that 
proteins affected by epistasis were more likely to be linked with each other than with 
proteins that are not affected by epistasis and vice versa (Fig 10A).  There are 199 
edges between two proteins affected by epistasis and 85 edges between two proteins 
not affected by epistasis. However, only 75 edges involved proteins of both types (Fig. 
10C). This structural organization of the coexpression network suggests that the 
responses of proteins affected by environmental epistasis are controlled by a different 
mechanism than the responses of those not affected by environmental epistasis. 
 Previous studies indicate that proteins linked in a coexpression network are likely 
to function in the same pathway (Stuart et al. 2003). We hypothesized that the grouping 
of proteins upon classification into environmental interaction classes might be driven by 
their functional associations.  If true, we would expect to find more edges in the 
coexpression network between proteins within the environmental classes. Indeed, we 
found this result in this network.  Our data show that 299 of the edges (83%) are 
between proteins in the same environmental interaction class, while only 60 are 
between proteins in different classes (Fig 10D). 
Discussion 
Using the concepts of gene interactions and epistasis, we have developed a 
unifying conceptual framework to understand the cellular responses to complex 
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environmental stimuli. Although, we have only explored the cases with complete 
dominance of a stimulus, it is possible that both the stimuli contribute to a change in 
expression. It is also possible that many stimuli contribute towards a change. We 
speculate that the tools and approaches developed for gene-gene interactions involving 
multiple genes can be applied in such cases (Cordell 2009). In addition to linear 
regression modeling and ANOVA, we also tested our hypothesis using one sample and 
two sample t-tests of independence. The results from both approaches were in good 
agreement. 
The effect of mixtures of compounds has been actively studied in toxicology, 
especially in the context of environmental toxins (Altenburger et al. 2013; Hermens, 
Leeuwangh, and Musch 1985; Belden, Gilliom, and Lydy 2007; Altenburger, Nendza, 
and Schüürmann 2003; Altenburger et al. 2012; Altenburger, Walter, and Grote 2004; 
Berenbaum 1989; Deneer 2000; Greco, Bravo, and Parsons 1995; J.-H. Lee and 
Landrum 2006; Schoen 1996; Faust et al. 2001). These studies have led to the 
development of three complementary models to predict the combined effects of 
compounds in a mixture: (1) in the concentration addition model the total toxicity of a 
mixture is the sum of the individual toxicities of the component compounds, (2) in the 
independent action model the toxicities of the components of a mixture are independent 
of each other, and (3) in the simple interaction model the individual components, at the 
concentrations being tested, are not toxic, but are toxic when used together in a 
mixture. These models have been successful in predicting the total toxic effects of 
mixtures of compounds in many cases (Hermens, Leeuwangh, and Musch 1985; 
Belden, Gilliom, and Lydy 2007; Altenburger, Nendza, and Schüürmann 2003; 
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Altenburger et al. 2012; Altenburger, Walter, and Grote 2004; Deneer 2000; Faust et al. 
2001) . However, it is not immediately clear which one to apply in a specific case 
without model fitting (Belden, Gilliom, and Lydy 2007).  
Environmental interactions and epistasis can be extrapolated to explain the three 
models.  For example, the concentration addition model can be the case of incomplete 
dominance where many stimuli affect the biological processes under investigation. This 
would happen if the compounds in the mixture affect similar biological pathways. If the 
actions of the compounds are antagonistic to each other, it may lead to either the 
dominance or the suppression interaction. If their actions are not antagonistic, the 
combined effect would be the sum of the individual effects which could be observed as 
the non-specific environmental response.  
The independent action model explains the case where the compounds under 
investigation act upon different pathways (Altenburger et al. 2013; Altenburger, Nendza, 
and Schüürmann 2003; Altenburger et al. 2012; Altenburger, Walter, and Grote 2004; 
Greco, Bravo, and Parsons 1995; Schoen 1996). This is similar to a gene interaction 
where two mutations have two unrelated phenotypes and both phenotypes persist in the 
double mutant. By applying the logic of environmental interaction to this model, we can 
deduce that the changes induced by a mixture that follows the independent action 
model would have elements specific to the component compounds of the mixture. 
Additionally, the changes important to a specific compound would persist in the 
combinatorial condition, which could be used to identify molecules and pathways that 
respond to the specific compound in the mixture.  
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The simple interaction model explains the cases where the compounds 
individually have little or no toxicity, but are toxic when applied together (Berenbaum 
1989; Greco, Bravo, and Parsons 1995). In terms of environmental interaction, this 
could be a case of the discordance interaction. The effects explained by this model 
could also be a special case of environmental epistasis, where the combined effect of 
compounds is more than the sum of their individual effects. It is worth noting that 
although we discuss only three of the mixture toxicity models, there are a number of 
other models that explain the toxicities of compounds in a mixture (Hermens, 
Leeuwangh, and Musch 1985; Altenburger et al. 2013; Belden, Gilliom, and Lydy 2007; 
Altenburger, Nendza, and Schüürmann 2003; Altenburger et al. 2012; Altenburger, 
Walter, and Grote 2004; Berenbaum 1989; Deneer 2000; Greco, Bravo, and Parsons 
1995; J.-H. Lee and Landrum 2006; Schoen 1996; Faust et al. 2001). Environmental 
interactions and epistasis provides a conceptual framework unifying the different toxicity 
models. The interpretation of results can be made simpler using environmental 
interactions and epistasis.  
Phenotypic plasticity provides the conceptual framework for studying the 
interaction between genotype and environment. Phenotypic plasticity is the ability of an 
organism to change its phenotype in response to changes in the environment (Scheiner 
1993). It has been used to explain the ability of the same genotype to generate different 
phenotypes in different environments (Scheiner 1993).  However, phenotypic plasticity 
considers the environment as a monolithic entity. It fails to separate the relative 
contributions of the different environment components, for example; physical 
components such as temperature and pressure, chemical components such as 
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nutrients, and signaling molecules that activate different pathways. Applying 
environmental interactions and epistasis would help parse out the individual 
contributions of the stimuli towards the change in the phenotype. 
Similar to genetic epistasis, our data show that the effects of individual 
environmental stimuli are not necessarily additive.  Proteins affected by environmental 
epistasis are distributed throughout the genome and do not appear to be clustered at 
specific locations in the genome (Fig. 11). The prevalence of environmental epistasis in 
determining the changes in the proteome suggests that epistasis needs to be taken into 
account when building mathematical models of gene expression.  
Consideration of environmental epistasis is especially important in light of the 
recent attempts to build quantitative linear regression models of gene expression in 
which the independent variables are the environmental stimuli and the dependent 
variable is gene expression (Nagano et al. 2012). Interestingly, in a linear regression 
modeling study of transcriptional regulation in rice under native conditions, the 
regression model was able to predict gene expression under native conditions even if 
the environmental parameters varied slightly from those used for building the model. 
However, the predictive power of the regression model was reduced under controlled 
laboratory conditions suggesting that there may have been unknown epistatic 
interactions in the native conditions absent in the controlled lab conditions (Nagano et 
al. 2012).   
 73 
 
 
Figure 11 - Visualization of S. cerevisiae genomic locations of the proteins quantitated with fold changes 
represented as a heatmap using Circos plot 
Outermost circle- chromosomes, Second circle-fold changes of proteins with HT stimulus, Third circle-fold 
changes of proteins with G stimulus, Fourth circle-fold changes of proteins with HT+G stimuli, innermost 
circle-whether affected by epistasis or not (Purple: Affected by environmental epistasis, Orange: Not 
affected by environmental epistasis). 
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Concurrently applied environmental stimuli behave similarly to genetic elements 
in the way they interact to regulate the biochemical states of the cells. The observation 
of environmental interactions and epistasis in determining the states of both the 
proteome and transcriptome in diverse experimental conditions suggests the prevalence 
of this phenomenon in nature. Essentially, environmental interaction in concert with 
phenotypic plasticity and gene interactions can be envisaged as a mathematical 
operator with three components that determines the changes in the biochemical state of 
the cell.  The gene interaction component is derived from the effects of the genetic 
elements, while the environmental interaction component results from the effects of all 
the environmental stimuli. When the gene and environmental interactions are not 
independent of each other, phenotypic plasticity accounts for the deviations of the 
observed from the expected characteristic or trait. Most studies so far have treated 
phenotypic plasticity, gene interactions, and environmental interactions separately due 
to a lack of a common unifying framework (Cordell 2002; P. C. Phillips 1998; St 
Johnston 2002; Visser, Cooper, and Elena 2011; Mani et al. 2008; Altenburger et al. 
2013; Belden, Gilliom, and Lydy 2007; Altenburger, Nendza, and Schüürmann 2003; 
Altenburger, Walter, and Grote 2004; Greco, Bravo, and Parsons 1995; Scheiner 1993; 
Via and Lande 1985; Carl D. Schlichting and Levin 1984; Gerard, Vancassel, and 
Laffort 1993; C. D. Schlichting and Pigliucci 1993; Wilson and Lindow 1993; Tonsor, 
Elnaccash, and Scheiner 2013). Our data suggest that as an abstraction, environmental 
stimuli can be treated as genes to build a conceptual framework that combines the 
effects of genes and stimuli.  Environmental interactions and epistasis play a critical role 
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in cellular homeostasis as seen in this study’s patterns of change in the proteome and 
the transcriptome.  
Our data also suggest that a protein or a transcript is more likely to be critical for 
responding to a dominant environmental stimulus than to a recessive one. This could 
lead to more efficient experiment designs for identifying factors directly affected by an 
environmental stimulus. For example, experiments could be designed in which an 
unrelated stimulus B is applied concurrently with the stimulus of interest A.  The proteins 
or transcripts, for which the effect of A is dominant, would be more likely to be directly 
affected by stimulus A. We speculate that the same approach may be extended to 
genetic perturbations. In this case, an environmental stimulus could be applied in 
conjunction with the genetic perturbation. As with two concurrent environmental stimuli, 
a transcript or a protein for which the genetic perturbation is dominant may be more 
likely to be directly affected by it.  Therefore, using dominance, environmental 
interactions can also be used to devise studies to identify agents, such as regulatory 
RNAs, proteins, or small molecules which are critical for driving a range of biological 
processes in health and disease including drug interactions, adaptation in tumor 
microenvironment and immune responses.  
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Chapter III 
Carbon Source Alters the Protein Composition of Ribosomes for 
Translational Control 
Abstract 
Ribosomes are the catalytic engines that drive protein synthesis. More recently, 
the role of ribosome in gene expression regulation has come under increased focus. In 
this study, I have explored the role of ribosomal proteins in translational control. I used 
iTRAQ labeling followed by liquid chromatography tandem mass spectrometry based 
protein quantitation and cryo-electron microscopy single particle classification and 
reconstruction to assay the changes in the protein composition of the ribosomes. I 
identified Rpl8a and Rpl8b as a candidate paralog pair whose change in abundance on 
the ribosomes is important for the ribosome filter mediated translational control. My data 
using yeast genetics and polysome profiling shows that Rpl8a and Rpl8b are not 
completely interchangeable. I found evidence supporting the presence of 
substoichiometric ribosomes and regulation of their proportions in response to changes 
in the carbon source. 
Introduction 
Gene expression can be regulated at multiple levels, including transcription and 
translation. Regulation of translation, also known as translational control, is a major 
mechanism modulating eukaryotic gene expression. Translation is the process, driven 
by ribosomes as the catalytic engines, by which the information encoded in an mRNA is 
used to synthesize a protein. Translational control is the regulatory mechanism through 
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which the protein synthesis machinery is regulated to control the information flow from 
mRNA transcripts to proteins. The protein and RNA accessory factors play an active 
role in this process. The ribosomes were initially considered passive players (Kapp and 
Lorsch 2004; Dever and Green 2012; Sonenberg and Hinnebusch 2009; Hinnebusch 
2015).  
In recent years, the idea that the ribosomes are regulatory elements in gene 
expression regulation has been gaining ground. The role of ribosome in the regulation 
of gene expression is a very active area of research (Ruggero and Pandolfi 2003; 
Kondrashov et al. 2011; Xue et al. 2015; Jonathan R. Warner and McIntosh 2009; 
Jonathan R. Warner 2015; McIntosh and Warner 2007; Komili et al. 2007). Two 
complementary mechanisms have been proposed to explain the regulatory functions of 
ribosomes. In the first model, ribosomes act as reservoirs of regulatory molecules that 
are released upon specific cellular cues. This model is called the depot hypothesis 
(Ray, Arif, and Fox 2007; Mazumder et al. 2003). An important example of this mode of 
action is the role of RPL13A protein in inflammatory response (Mazumder et al. 2003; 
Kapasi et al. 2007).  
The second model is based upon the heterogeneity in the protein and rRNA 
compositions of the ribosomes. In baker’s yeast Saccharomyces cerevisiae, 138 
ribosomal protein genes are present. This includes 59 duplicated paralog pairs. The 
amino acid sequences of the paralogs are not identical. There are nearly 150 copies of 
rRNA genes in yeast. These copies are not identical (McIntosh and Warner 2007; Komili 
et al. 2007; Jonathan R Warner 1999). Ribosomal proteins have been found to be post-
translationally modified. Post-translational modifications add another level of complexity 
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to the ribosomal subpopulations (Martin et al. 2014; S. Ramagopal 1992). Taking these 
observations into account, Vincent Mauro and Gerald Edelman proposed the ribosome 
filter hypothesis. According to the hypothesis, different ribosomes with differing 
composition translate specific mRNAs more efficiently (Mauro and Edelman 2002; 
Vincent P Mauro and Gerald M Edelman 2007). 
In addition to the heterogeneity in ribosome composition due to the use of a 
specific paralog, a post-translational modification and a difference in the rRNA 
sequence, two other potential sources of heterogeneity involving the core components 
of the ribosomes are possible. In one model, a ribosomal protein can be present in more 
than one copy on the ribosome. We call this the superstoichiometric composition model 
in which subpopulations of ribosomes carrying extra copies of a ribosomal protein can 
act either as a depot of the regulatory extra copy ribosomal protein, or translate certain 
mRNA with higher efficiency. In the second model, a ribosome can be missing 
ribosomal protein(s) or sequences of rRNA. We call this the substoichiometric model. 
Similar to the superstoichiometric model, these ribosomes might have acted as a depot 
of the regulatory missing ribosomal protein(s). Alternatively, the substoichiometric 
ribosome can translate specific mRNAs at a higher efficiency. 
The publication of ribosome filter hypothesis has provided a conceptual 
framework in which to understand the role of ribosomal heterogeneity, and the ribosome 
has received increased attention as a regulatory factor in recent years (Xue and Barna 
2012; McIntosh and Warner 2007). The ribosome filter hypothesis has gained support 
from many subsequent studies (A. S.-Y. Lee, Burdeinick-Kerr, and Whelan 2013; 
Kondrashov et al. 2011; Komili et al. 2007; Xue et al. 2015). A large body of work has 
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concentrated on the rRNAs and suggests that ribosomes are indeed regulatory 
elements, and that rRNA heterogeneity arising from multiple copies of rRNA genes 
plays an important role in this process (Vincent P Mauro and Gerald M Edelman 2007; 
Mauro and Edelman 1997; Owens et al. 2001; Hu et al. 1999).  
There is also evidence that suggests the heterogeneity in ribosomal proteins 
results in differences in translational efficiency (S. Ramagopal 1992). A comparison of 
protein composition of ribosomes from skeletal muscles and liver in rats using 2-
dimensional gel electrophoresis revealed differences between the ribosomes from the 
two tissues (Sherton and Wool 1974). This suggested a differential requirement of 
ribosomal proteins in different mammalian tissues. Dictyostelium discoideum, ribosomes 
from spores and vegetative cells differ in protein composition and posttranslational 
modification (S. Ramagopal 1992). This suggested a differential temporal requirement 
of ribosomal proteins and their post-translation modifications in organismal 
development. In S. cerevisiae, deletion of one of the paralog pairs often results in a 
different phenotype from that of the other paralog, indicating that that the different 
paralogs have different roles (Komili et al. 2007; Giaever et al. 2002; Breslow et al. 
2008). Pamela Silver and co-workers demonstrated that translation of the S. cerevisiae 
ASH1 mRNA is more efficient in the presence of particular paralogs (Komili et al. 2007). 
Studies in Maria Barna lab has shown that Rpl38 is needed for efficient translation of 
specific Hox mRNAs (Xue et al. 2015; Kondrashov et al. 2011). In another study, Rpl40 
was found to be required for translation initiation of vesicular stomatitis virus (VSV) 
mRNAs (A. S.-Y. Lee, Burdeinick-Kerr, and Whelan 2013). Hyper-phosphorylation of S6 
has been implicated in upregulation of protein synthesis (Thomas et al. 1982; Duncan 
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and McCONKEY 1982).  The phosphorylation of S6 has been proposed to increase the 
affinity of the ribosomes for TOP-element containing mRNAs, although there are 
conflicting observations in mice (Ruvinsky et al. 2005; Volarević and Thomas 2000; 
Ruvinsky and Meyuhas 2006).  
Taken together, these studies have provided strong evidence in support of the 
ribosome filter hypothesis. However, the hypothesis is yet to be directly tested. This has 
been mainly because of the difficulty in identifying both the ribosomes with a specific 
composition and the mRNAs that they translate more efficiently. To identify both the 
ribosome and the transcripts, I devised a simple strategy based upon a corollary of the 
ribosome filter hypothesis. Cells growing in one growth condition require a specific 
proteome that is optimum for that condition. Cells growing in a different condition will 
require a different proteome. Therefore, if the ribosome filter hypothesis is correct, the 
complement of ribosomes required to synthesize the two proteomes will be different 
(Figure 1). Quantification of the ribosomal proteins in the purified ribosomes should 
allow identification of the paralogs whose requirements are different. Once a paralog 
has been identified, ribosome profiling of null mutants will allow identification of the 
transcripts whose translation is affected by specific paralogs. Using this strategy in 
yeast cells growing with glucose or glycerol as carbon source, I have identified the 
paralog pair Rpl8a and Rpl8b as candidate ribosomal proteins with differential 
requirements for specific transcripts. Polysome profile analysis using heterozygous 
diploid null mutants, rpl8a and rpl8b, suggests that the functions of Rpl8ap and rpl8bp 
are not inter-changeable. Using cryo-electron microscopy in collaboration with the 
Joachim Frank lab, I have found evidence in favor of substoichiometric ribosomes. A 
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time course experiment coupled with cryo-EM revealed that the proportions of 
substoichiometric ribosomes changed in response to change in carbon source from 
glucose to glycerol. 
Materials and methods 
Strains and Media. All yeast media, growth, and genetic manipulation was done using 
standard techniques (Amberg, Burke, and Strathern 2005).The diploid strain BY4743 
has been previously described (Baker Brachmann et al. 1998).  
Preparation of protein extract and ribosome purification: Three biological replicates 
were used for each growth conditions tested, YPD at 30 oC and YPG at 30 oC. A 5ml 
overnight culture in YPD (1% yeast extract, 2% peptone, 2 % glucose) was inoculated 
from a single yeast colony from a YPD agar plate.  Fifty ml of YPD at 30 oC was 
inoculated with 50 µL of the overnight culture.  One hundred ml of YPG at 30 oC (1% 
yeast extract, 2% peptone, 3% glycerol) inoculated with 1 ml of the overnight culture. 
The twelve cultures were grown side-by-side with constant shaking at 175 rpm in an 
Innova 44 shaker incubator (New Brunswick Scientific). For all four growth conditions, 
cells were harvested at mid-log phase as determined by OD600 measurements.  Cells 
growing in YPD were harvested after 14 h, while cells  in YPG were harvested after 24 
h. All cultures were centrifuged at 2000 rpm for 5 min at 4 oC using a Sorvall 
HLR6/H600A/HBB6 rotor in Sorvall RC-3B centrifuge and washed with ice cold 
deionized H20.  The cell pellets were resuspended in 1 mL ice cold wash buffer (10 mM 
Tris pH 8, 5 mM beta- mercaptoethanol, 500 mM ammonium chloride, 100 mM 
magnesium acetate) and lysed at 4 oC using glass beads and a Bead Beater (BioSpec, 
Inc) for 10 min as previously described (Browne et al. 2013).  The whole cell extracts 
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(WCE) were clarified by centrifugation at 20,000g for 15 min at 4 oC and a 200 µL 
aliquot of the cleared WCE was stored at -80 oC.  The remaining cleared WCEs were 
overlaid onto a 5/20% discontinuous sucrose gradient prepared in wash buffer. The 
gradients were centrifuged at 28,000 RPM using a SW-41 swinging bucket rotor for 18 h 
at 4 oC. The supernatant was discarded and the ribosome pellet was resuspended in ice 
cold 1 mL standard buffer (10 mM Tris pH 8, 5 mM beta-mercaptoethanol, 50 mM 
ammonium chloride, 5 mM magnesium acetate) and centrifuged for 10 min at 10,000g 
at 4 oC.  The pellet was discarded and the ribosome suspension was stored at -80 oC. 
For cryoEM analysis, ribosomes were purified as above after shifting the cells grown in 
glucose to glycerol and taking aliquots at the following time points: 0Min, 30Min, 60Min, 
120Min, 240Min, and 450Min. 
iTRAQ labeling: The total protein concentration of all ribosome suspensions were 
determined using Bradford assay according to the manufacturer protocol (Sigma 
Aldrich, St. Louis, MO. Catalog # B6916-500ML). Fifty micrograms of total protein from 
each growth condition was mixed with 50 ng of bovine serum albumin (Thermo 
Scientific, #23209) as an internal standard.  Each protein sample was acetone 
precipitated and resolublized in 25 µL iTRAQ dissolution buffer (500 mM 
triethylammonium bicarbonate, 0.1 % sodium dodecyl sulfate).  The proteins were 
reduced with tris(2-carboxyethyl)phosphine at 60 oC for 60 min and the cysteines were 
derivatized with methyl methanethiosulfonate at RT for 10 min.  All samples were 
digested with sequencing grade modified trypsin (1:50; Promega Corporation, Catalog # 
V5111) overnight at 37 oC. An equal fraction of the tryptic digest of ribosomes from the 
3 replicates grown in YPD at 30 oC were pooled separately and used as a control for the 
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iTRAQ experiments. Ten µg from each replicate tryptic digested sample and pooled 
control were used for iTRAQ labeling. The iTRAQ labeling reagents were resolublized in 
150 µL anhydrous ethanol (Sigma Aldrich, St. Louis, MO. Catalog # E7023-500ML). 
Seventeen µL of iTRAQ reagents were added to each 10 µg sample and the pooled 
control, incubated with shaking for 1 h at room temperature on Eppendorf Thermomixer 
R, pooled, frozen, lyophilized, resolublized in X ul of buffer A (0.1 % formic acid in 
HPLC-grade water), and stored at -80 oC. 
Liquid chromatography and mass spectrometry:  The iTRAQ labeled samples were 
analyzed with MudPIT as previously described (Browne et al. 2013). Precursor ions 
were analyzed in the Orbitrap mass analyzer followed by 4 CID fragment ion scans in 
the ion trap and 4 HCD fragment ion scans (normalized collision energy  = 45%) in the 
Orbitrap.  
iTRAQ data analysis: The data analysis workflow essentially mirrored the workflow 
described in Chapter II. Briefly, RAW files generated by the MudPIT experiments were 
searched using the Sequest database search engine running under Proteome 
Discoverer v1.4 (Thermo Scientific) against a forward and reverse yeast protein 
database (S.cererevisiae_orf_trans_all_SGD.fasta.6718) with appended common 
contaminant sequences (Eng et al. 2008; Eng, McCormack, and Yates 1994). Protein 
assembly and reporter ion quantitation and statistical analysis were done using 
ProteoIQ (Premier BioSoft Inc). Principal component analysis was done using princomp 
function in R and the PCA plot was generated using Scatterplot3d package (R Core 
Team 2015; Ligges and Mächler 2003). Boxplots were generated in RStudio. All python 
and R scripts used in this study will be made available on request. 
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Multiple Reaction monitoring: Proteotypic peptides were selected for targeted 
quantitation from a database of identified peptides in the MudPIT experiments. 
Transitions for unscheduled scout experiments were selected based upon NIST and 
GPM spectral libraries. Fifty µg of the purified ribosomes were digested with sequencing 
grade modified trypsin (1:50; Promega Corporation, Catalog # V5111) and desalted 
essentially as described (Browne et al. 2013). Peptides were eluted using an elution 
buffer composition of 50% Acetonitrile, 0.1% Trifluoroacetic acid. Peptides were 
analyzed using a 90 min scheduled SRM analysis.  Briefly, peptides were autosampled 
onto a 200 mm by 0.1 mm (Jupiter 3 micron, 300A), analytical column coupled directly 
to an TSQ-Vantage (ThermoFisher) using a nanoelectrospray source and resolved 
using an aqueous to organic gradient (1-45% Buffer B) at X ul/min flow rate.  Using 
series of unscheduled scout runs to determine retention times and transitions to 
monitor, a scheduled instrument method encompassing a 10 min window around each 
retention time along with calculated collision energies was created using Skyline 
(MacLean et al. 2010).Q1 peak width resolution was set to 0.7, collision gas pressure 
was 1 mTorr, and utilized an EZmethod cycle time of 5 s. The resulting RAW instrument 
files were imported into Skyline for peak-picking and quantitation (MacLean et al. 2010). 
The peak areas of the transitions were exported and further analysis done in Microsoft 
Excel. Sum of the peak areas of all the transitions of a given peptide, peptide peak area, 
was used as the quantitative measure of abundance for the peptide. The average of 
peptide peaks areas of all the peptides from a given protein, protein peak area, was 
used as the quantitative measure of abundance of the protein. The average protein 
peak areas of single copy ribosomal protein RPL5 was used as control.  For differential 
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analysis, in the first step a ratio of peak area of the test protein to the peak area of the 
control was calculated across all samples. In the next step, two sample t-test with alpha 
level 0.05 was performed with the ratios to test for statistical significance. Finally, fold 
change was calculated by ratioing the average of ratios. The calculated was fold 
changes were log2 transformed. 
Cryoelectron Microscopy (in collaboration with the Joachim Frank lab): For each 
specimen of the time series, ribosome samples were applied to Holey carbon-coated 
Quantifoil copper grids, freeze-plunged using the Vitrobot Mark IV freeze-plunger (FEI, 
Portland, Oregon), and then visualized in an FEI Tecnai F20 electron microscope at 200 
kV acceleration voltage and 5,000x magnification, using a 4k x 4k CCD camera (Gatan, 
Pleasanton, CA) and automated data collection employing the programs Leginon and 
Appion (Grassucci, Taylor, and Frank 2008; Suloway et al. 2005). Each pixel 
corresponds to 2.25A on the object scale. A total number of 260,440 particles were 
selected from 2,661 micrographs. Of these, 159,654 were verified using a work-flow 
written in Arachnid, and processed using the program RELION, which combines 
maximum likelihood-based classification with reconstruction, as well as a novel 
convergence analysis that finalizes the classification results (Bo Chen, Shen, and Frank 
2014; Scheres 2012).  For a comprehensive analysis of the time series, all data were 
pooled together so that increase and decrease of each sub-population could be 
effectively studied, and the maximum number of particles was available for the 3D 
reconstruction of each class. 
GOzilla: GOzilla is a custom Python script. It uses GO Slim database from 
Saccharomyces cerevisiae Genome Database (SGD) (Cherry et al. 1998; Christie et al. 
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2004). In the first step COMPzilla creates a dictionary with GO terms as the keys and 
the proteins that have the given GO term associated with them in the GO Slim database 
as the values. In the next step, GOzilla creates a dictionary in which GO terms are still 
the keys, but values are fold changes corresponding to the proteins that were mapped 
to GO terms in the first step. In the third step, GOzilla creates a list all the fold changes 
in the experiment that will be considered the population of fold changes for statistical 
testing. Finally, GOzilla compares the fold change distribution associated with the GO 
terms with population fold change distribution using two sample t-test of independence 
and two sample Kolomogorv-Smirnov test. GOzilla exports the results of the two tests in 
separate tab delimited text files, in which first column contains the GO terms, the 
second column t-statistics or ks-statistics, and the third column contains the 
corresponding p-value (Source code in Appendix R).  
COMPzilla: COMPzilla is a custom Python script. It uses CYC2008 2.0, a manually 
curated database of biomolecular complexes in yeast to identify complexes that are 
differentially present (Pu et al. 2007; Pu et al. 2009). In the first step COMPzilla creates 
a dictionary with complex names as keys and the proteins that constitute the complex 
as values. In the next step, COMPzilla creates a dictionary in which complex names are 
still the keys, but values are mapped fold changes of the proteins that constitute the 
complex. In the third step, COMPzilla creates a list all the fold changes in the 
experiment that will be considered the population of fold changes for statistical testing. 
Finally, COMPzilla compares the fold change distributions associated with protein 
complexes with population fold change distribution using two sample t-test of 
independence and two sample Kolomogorv-Smirnov test. COMPzilla exports the results 
 87 
 
of the two tests in separate tab delimited text files, in which first column contains the 
complex names, the second column t-statistics or ks-statistics, and the third column 
contains the corresponding p-value. (Source code in Appendix S) 
Results 
Ribosomal proteins abundances are regulated in response to environmental 
stimuli but the abundances of all RPs do not change to the same extent. 
 To investigate the regulation of abundances of ribosomal proteins in response to 
environmental stress, we reanalyzed our previously published dataset using Python 
scripts GoZilla.py and CompZilla.py ((Source codes in Appendices R and S). The whole 
cell extract analyzed in this study were the sources for the purified ribosomes for this 
study (Samir et al. 2015). GoZilla identifies the Gene Ontology terms that are either 
downregulated or upregulated in a gene expression data. It uses the Go Slim database 
downloaded from Saccharomyces genome database for looking up GO terms (Cherry et 
al. 1998; Christie et al. 2004). CompZilla identifies the differentially regulated 
biomolecular complexes in gene expression data. It uses a manually curated database 
of yeast biomolecular complexes to lookup their constituents (Pu et al. 2007; Pu et al. 
2009).  
 In the three stimuli used in the previous study, most of the proteins with structural 
constituent of ribosome GO terms were downregulated (Fig. 12A). Similarly most of the 
components of 60S and 40S ribosomal subunits were downregulated too (Fig. 12B). 
However, the log2 transformed fold changes were not consistent for all of the ribosomal 
proteins. This suggested that at least some of the ribosomal proteins were being 
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differentially regulated compared to others. This is in agreement with the predictions of 
both ribosome filter hypothesis and the depot hypothesis (Mauro and Edelman 2002; 
Ray, Arif, and Fox 2007; Mazumder et al. 2003). However, this does not exclude the 
possibility that the changes in ribosomal protein abundances were independent of the 
changes in the protein composition of ribosomes themselves. 
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Figure 12 - : Analysis of whole cell extract quantitative protoemics data using GoZilla and CompZilla. 
A) A boxplot showing the fold change distribution of proteins with structural constituent of ribosome GO 
term. GoZilla was used to generate the fold change distribution. Boxplots were generated in RStudio. B) 
Fold change distributions of 40S and 60S subunit proteins. CompZilla was used to generate the fold 
change distribution. Boxplots were generated in RStudio. 
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Quantitative proteomics analysis of protein abundances in purified ribosomes. 
To directly measure the changes in the protein composition of ribosomes, we 
focused on two environmental stimuli – (1) growth in rich media with glucose as carbon 
source at 30 oC, and (2) growth in rich media with glycerol as carbon source at 30 oC. 
We purified the ribosomes using a discontinuous sucrose gradient centrifugation. We 
analyzed the samples using iTRAQ labeling followed by liquid chromatography tandem 
mass spectrometry. We identified 135 ribosomal proteins, 131 of which were 
quantitated in the three replicates. Since the ribosomes were purified from the same 
whole cell extracts used in the previous study, we compared the fold changes of 
ribosomal proteins in purified ribosomes to that in the whole cell extracts (Samir et al. 
2015). Surprisingly, a correlation matrix analysis revealed that there was no correlation 
between the two fold changes (Fig. 13A-D). There was good correlation in the ribosomal 
protein levels between the replicates, both in whole cell extracts and purified ribosomes 
(Fig. 14A-F). This suggested that the lack of correlation was not due to a noisy data with 
high variance. 
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Figure 13 – Correlation analysis between the changes in whole cell extracts and purified ribosomes 
There are three replicates each corresponding to WCE and purified ribosomes. A) Cross0correlation 
matrix, numbers represent Pearson’s R, W# represent whole extracts, R# represent purified ribosomes. 
B-D) Scatter plots showing relationship between fold changes in whole cell extract (X-axis) and purified 
ribosomes (Y-axis) Three replicates are depicted.  
 92 
 
 
Figure 14 - Scatterplots showing reproducibility among replicates of whole cell extracts and purified 
ribosomes 
Sctterplots were generated in RStudio. A-C) Scatterplots of whole cell extracts. Replicate 1 vs Replicate 
2, Replicate 1 vs Replicate 3, and Replicate 3 vs Replicate 2. D-F) Scatterplots of purified ribosomes. 
Replicate 1 vs Replicate 2, Replicate 1 vs Replicate 3, and Replicate 3 vs Replicate 2.
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Figure 15 – Quantitation of ribosomal proteins in purified ribosomes using quantitative mass spectrometry 
A) 45 ribosomal proteins quantitated using at least one unique peptides in iTRAQ experiments. B) 11 
Differentially present ribosomal proteins in purified ribosomes identified using t-test p-value less than 
0.05. C) The amounts of RPL8A and RPL8B were validated using multiple reaction monitoring approach 
in three independently purified ribosomes. These were different samples from the ones used in iTRAQ. 
To identify differentially present ribosomal proteins, we used t-test of 
independence with alpha level of 0.05. Since there are minimal sequence differences 
between the paralogs, to reliably quantify the paralog specific changes we reanalyzed 
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the mass spectrometry data to use only the unique peptides for quantitation. We 
quantitated 45 ribosomal proteins with at least one unique peptide, 11 of which were 
differentially present in the purified ribosomes (Fig. 15A-B). This included a paralog pair, 
Rpl8a and Rpl8b (Fig. 15C). We validated the iTRAQ data using multiple reaction 
monitoring. 
Using CryoEM to detect changes in the ribosomal protein composition over time. 
Quantitative proteomics is a population based technique that could not address 
superstoichiometric and substoichiometric models for changes in the protein 
composition of ribosomes. To determine the changes in the protein composition of 
ribosomes consistent with superstoichiometric and substoichiometric models, we used 
cryoEM in collaboration with the Joachim Frank lab at Columbia University. We focused 
on the changes in 80S ribosomes. We identified 3 populations of ribosomes, (1) a 
population of complete 80S ribosomes that has the full complement of ribosomal 
proteins, (2) a population of 80S ribosomes missing Rpl10 (ΔuL16), and (3) a population 
of ribosomes missing both Rpl10 and Rps1 (ΔuL16 ΔeS1) electron densities (Fig. 16A). 
We did not observe ribosomes with superstoichiometric composition of ribosomal 
protein(s) in our data.  
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Figure 16 - Cryo-EM analysis 
A) Electron densities corresponding to Rpl10 (uL16) and Rps1 (eS1) in cryo-EM structures. 
Substoichiometric ribosomes lacking these proteins were identified. B) Time-course analysis to measure 
the dynamic changes in the proportions of ribosomes missing uL16 or both uL16 and eS1. 
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To study the kinetics of change in the composition of 80S ribosomes, we 
performed a time-course experiment to track the proportions of these sub-populations. 
The cells were grown in with glucose as the carbon source. At time 0 minutes, the cells 
were spun down and resuspended in media containing glycerol as the carbon source. 
We aliquoted cells at 0, 30, 60, 120, 240, and 450 minutes after shifting from glucose to 
glycerol. We purified ribosomes from these cells and used cryo-EM to determine the 
relative proportions of the three structures (Fig. 16B). The proportion of complete 
ribosomes decreased sharply within the first 30 minutes of the shift. There was a similar 
increase in the proportion of ΔuL16 ΔeS1 ribosomes in the same time frame. After 60 
minutes, the proportion of complete ribosomes started to recover with a concomitant 
decrease in the ΔuL16 ΔeS1 ribosomes. However, the proportions of complete and 
ΔuL16 ΔeS1 ribosomes never recovered to the initial level in the time frame used in this 
study. The proportion of ΔuL16 ribosomes continued to steadily increase throughout our 
experiment. However, the rate of increase was minimal. The substoichiometric 
composition is consistent with both the depot hypothesis and the ribosome filter 
hypothesis. 
Paralog specific roles of Rpl8a and Rpl8b in translation using null mutants. 
 We used polysome profile analysis to study the paralog specific roles of Rpl8a 
and Rpl8b in global translational control. We used the rpl8a and rpl8b null mutants that 
had been previously described (Winzeler et al. 1999). We used the diploid wild type 
(BY4743) and null mutant strains (Baker Brachmann et al. 1998; Winzeler et al. 1999). 
Similar to the proteomics analysis, we grew cells with either glucose or glycerol as 
carbon source (Fig. 17 and 18). Polysome profiles of rpl8a cells showed a large 
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increase in 40S peak and shoulders on the 80S and polysome peaks (Fig. 17B). The 
shoulder defect was rescued by either adding back Rpl8a or overexpressing Rpl8b from 
their native promoters (Fig. 17B, 17D, 17E). However, the 40S peak defect was rescued 
only by adding back Rpl8a (Fig. 17B, 17D, 17E). Polysome profiling of rpl8b cells did 
not show a difference from wild type (Fig. 17C). When the cells were grown with 
glycerol, rpl8a cells showed a very prominent 40S peak, which was rescued by adding 
back Rpl8a (Fig. 18B, 18D). This defect was not rescued by overexpression of Rpl8b 
(Fig. 18E). In glycerol, rpl8b cells too showed a larger 40S peak that was rescued by 
Rpl8b but not by Rpl8A (Fig. 18C, 18F, 18G).  
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Figure 17 – Polysome profiles with glucose as carbon source 
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A) Polysome profile of WT diploid strain BY4743. B) Polysome profile of rpl8a diploid null mutant. C) 
Polysome profile of rpl8b diploid null mutant. D) Polysome profile of rpl8a diploid null mutant with Rpl8a 
on a plasmid expressing from native promoter. E) Polysome profile of rpl8a diploid null mutant with Rpl8b 
on plasmid expressing from native promoter. F) Polysome profile of rpl8b diploid null mutant with Rpl8a 
on a plasmid expressing from native promoter. E) Polysome profile of rpl8b diploid null mutant with Rpl8b 
on plasmid expressing from native promoter. 
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Figure 18 – Polysome profiles with glycerol as carbon source 
A) Polysome profile of WT diploid strain BY4743. B) Polysome profile of rpl8a diploid null mutant. C) 
Polysome profile of rpl8b diploid null mutant. D) Polysome profile of rpl8a diploid null mutant with Rpl8a 
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on a plasmid expressing from native promoter. E) Polysome profile of rpl8a diploid null mutant with Rpl8b 
on plasmid expressing from native promoter. F) Polysome profile of rpl8b diploid null mutant with Rpl8a 
on a plasmid expressing from native promoter. E) Polysome profile of rpl8b diploid null mutant with Rpl8b 
on plasmid expressing from native promoter. 
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Figure 19 – Quantification of peak areas ratios of polysome profiles 
A) Ratio of 40S:60S peak areas. B) Ratio of 80S:Polysome peak areas. D is BY4743, AD is rpl8a diploid 
null, AAD is rpl8a diploid null with Rpl8a, ABD is rpl8a diploid null with Rpl8b on a plasmid, BD is rpl8b 
diploid null, BBD is rpl8b diploid null with Rpl8b, BAD is rpl8b diploid null with Rpl8a on a plasmid. 
We further analyzed the polysome profiles quantitatively by measuring the peak 
areas of the 40S, 60S, 80S, and polysome peaks. We used two parameters – (1) the 
ratio of 40S:60S peak areas (40/60 ratio), and (2) the ratio of 80S:Polysome peak areas 
(80/Poly ratio) (Fig. 19). Both rpl8a and rpl8b cells showed elevated 40/60 ratios with 
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either glucose and glycerol as carbon sources (Fig. 19A). In rpl8a cells. the ratios were 
rescued to the wild type levels by adding back Rpl8a (Fig. 19A). Although the 
overexpression of Rpl8b decreased the ratios, but it did not reach the wild type levels 
(Fig. 19A). In rpl8b cells too showed a similar pattern, with adding back Rpl8b rescuing 
the defect (Fig. 19A). Overexpression of Rpl8a was only able to partially rescue the 
defect (Fig. 19A). 
Analysis of 80S/Poly ratios showed no defectin either rpl8a or rpl8b cells when 
grown in glucose (Fig. 19B). Overexpression of Rpl8a or Rpl8b in the mutant cells did 
not lead to a defect either (Fig. 19B). When cells were grown in glycerol, there was an 
elevation in the ratio for rpl8b cells but not for the rpl8a cells (Fig. 19B). The elevated 
80S/Poly ratio defect was rescued by adding back Rpl8b but not by overexpression of 
Rpl8a (Fig. 19B). Taken together, the polysome profile analysis suggested paralog 
specific roles for Rpl8a and Rpl8b proteins. This is consistent with the ribosome filter 
hypothesis. 
Discussion 
 Presence of ribosomes with substoichiometric composition of ribosomal proteins 
presents intriguing possibilities. In E. coli, ribosomes lacking a 43 nucleotide segment 
on the 3’ end of the 16S rRNA selectively translates leaderless mRNA. This would be 
an example of a ribosome with substoichiometric composition, in this case a rRNA, 
acting as a filter for translating a specific class of mRNA. Do the ribosomes missing 
Rpl10, Rps1, or both translate a special class of mRNAs? It is also possible that Rpl10 
and Rps1 have extra-ribosomal functions similar to RPL13A in GAIT complex. There 
dissociation from the ribosome to perform their extra-ribosomal function may leave 
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behind ribosomes lacking their electron densities. Another intriguing possibility is that 
the dissociation of Rpl10 and/or Rps1 acts as a break. This is consistent with the 
observation that the proportion of ribosomes missing either of the two proteins 
increases rapidly immediately after shifting the carbon source (Fig. 16B). Since cells 
have to adapt to a new environment, they may pause for a time before making new 
proteins. Furthermore, the proportion of complete ribosomes never recovers to the pre 
shift stage during the time frame of this study. Since yeast cells grow very slowly with 
glycerol as carbon source compared to glucose, the ribosomes lacking one or both of 
the ribosomal proteins may be part of a non-translating reserve pool. Although we 
cannot differentiate between the three possibilities, the very presence of 
substoichiometric ribosomes suggests alternative biological models that would need to 
be addressed in future studies. 
 Although the change in composition of ribosomes with the changes in the growth 
condition was not completely unexpected, we provide experimental evidence that it 
does occur, at least in S. cerevisiae. The paralog specific roles of Rpl8a and Rpl8b 
observed in the polysome profiles provide direct evidence in favor of the ribosome filter 
hypothesis. In planned follow up experiments, we are using ribosome footprint profiling 
with the wild type and mutant cells to identify the mRNAs whose translation is 
differentially affected by either of the paralogs (Ingolia 2014). It would be very 
interesting to see if there are sequence features on the mRNAs under paralog specific 
translational control. A recent study in mouse has found RNA secondary structures in 5’ 
UTRs of a subset of Hox mRNAs (Xue et al. 2015). These RNA structures resemble 
internal ribosome entry sites required for the cap-independent translation initiation 
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mechanism. They are expected to recruit ribosomes to the mRNA through a mechanism 
dependent upon Rpl38 (Xue et al. 2015). 
 A number of single copy ribosomal proteins are differentially present in the 
purified ribosome samples in the proteomics experiment but not in the cryo-EM 
experiments focused on 80S ribosomes. There could be three possibilities that can 
explain these observations – (1) confounding of the mass spectrometry quantitation by 
impurities, unassociated 40S and 60S subunits, biogenesis or degradation 
intermediates, in the sample prep, (2) cofounding of the mass spectrometry quantitation 
by unidentified post-translational modifications, and (3) the changing composition in free 
40S and 60S subunits that were excluded from cryo-EM analysis. 
In our experiments, we pelleted down all of the ribosomes including 40S, 60S, 
and 80S. Our protocol would also have pelleted the ribosomes in the intermediate 
stages of biogenesis or degradation. We cannot differentiate between the tryptic 
peptides coming from the different sources in the sample. Each of these peptides 
contributes to quantification and potentially confounds our results. In cryo-EM, we 
focused only on the 80S ribosomes. We were able to filter out all the other sources of 
variation from our analysis. Therefore, cryo-EM provides a cleaner data for the single 
copy ribosomal proteins. However, cryo-EM cannot differentiate between the different 
paralogs at the resolutions routinely achieved through this approach. This makes 
quantitative proteomics and cryo-EM complementary techniques to address these 
different questions. 
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A second reason for the changes detected in the single copy ribosomal proteins 
could be the confounding by the unidentified post-translational modifications. Ribosomal 
proteins are known to be post-translationally modified (Ohn et al. 2008; Spence et al. 
2000; W. M. Anderson, Grundholm, and Sells 1975; Kruiswijk et al. 1978; Kaerlein and 
Horak 1976; Arragain et al. 2010; Nesterchuk, Sergiev, and Dontsova 2011; Xirodimas 
et al. 2008; Arnold et al. 1999; Thomas et al. 1982). The post-translational modification 
of peptides confounds mass spectrometry based quantitation if the modified peptides 
have been not been identified in the experiment. This is because the modification 
changes the mass as well as the retention time for a chromatography run. This leads to 
absence of signal that can be misinterpreted as differential presence. To minimize this 
possibility, use of two or more peptides for quantitation is recommended because the 
probability of both peptides being modified simultaneously is considered lower than an 
individual peptide. Although these precautions can minimize the chances of errors in 
quantitation due to post-translational modifications, it cannot completely rule them out. 
A third reason for the changes in the single copy ribosomal protein could be that 
the proportions of ribosomes missing these ribosomal proteins are changing between 
the two growth conditions. Although we did not observe the 80S structures missing 
these ribosomal proteins in cryo-EM analysis, they might be present in the ribosomal 
subunits or intermediates of biogenesis or degradation. 
In conclusion, we have showed the changing protein compositions of ribosomes 
using two complementary approaches. Paralog specific changes are consistent with the 
ribosome filter hypothesis. The changes in the single copy ribosomal proteins observed 
in the quantitative proteomics study and cryo-EM are consistent with both the depot 
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hypothesis and the ribosome filter hypothesis. The planned future studies are expected 
to shed light on the functional significance of the changing compositions. 
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Chapter IV 
Quantitative Proteomics Analysis of Human Myotonic Dystrophy 
Skeletal Muscles Reveals Specific and Common Modules of 
Differentially Expressed Proteins. 
Abstract 
Myotonic dystrophy, a form of muscular dsystrophy, is an autosomal dominant 
multi-systemic disorder caused by the expansion of nucleotide repeats.  There are two 
types of myotonic dystrophy. Myotonic dystrophy type 1 (DM1) is cause by a CTG 
trinucleotide repeat expansion in the 3’ untranslated region of dystrophia myotonica-
protein kinase (DMPK) gene.  Myotonic  dystrophy type 2 (DM2) is caused by a CCTG 
tetranucleotide repeat expansion in the first intron of zinc finger 9 (ZNF9) gene.  The 
expression of the repeat expansions in both cases lead to the nuclear accumulation of 
RNA granules, which sequester RNA processing factors.  This RNA toxicity is thought to 
be the cause of the disease symptoms. However, the effect of the repeat expansions on 
the proteome is poorly understood. 
To address this, we quantified the proteomes of the skeletal muscles of myotonic 
dystrophy patients and healthy volunteers to identify differentially regulated proteins. We 
used iTRAQ labeling followed by liquid chromatography tandem mass spectrometry for 
protein quantitation. Skeletal muscles from 5 healthy volunteers, 7 DM1 patients and 6 
DM2 patients were used in this study. We quantitated 3575 proteins across all the 
samples. We used one way ANOVA, with the Benjamini Hochberg procedure for 
controlling false discovery rate in multiple comparisons, to identify differentially 
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regulated proteins. We identified 30 proteins upregulated and 4 proteins downregulated 
in both DM1 and DM2. We found 154 proteins to be upregulated and 218 proteins to 
downregulated uniquely in DM1 patients. Pathway analysis of these proteins revealed 
biochemical pathways that appear to be affected by the repeat expansions. 
Introduction 
Myotonic dystrophy (DM) is an autosomal dominant multi-systemic disorder 
caused by the expansion of CTG or CCTG repeat elements in DMPK or ZNF9 genes, 
respectively. DM caused by the expansion CTG repeat in the 3’untranslated region of 
DMPK gene is called myotonic dystrophy type 1 (DM1) (Brook et al. 1992; Y. H. Fu et 
al. 1992; Mahadevan et al. 1992). It is also called Steinert’s disease and congenital 
myotonic dystrophy (Machuca-Tzili, Brook, and Hilton-Jones 2005). It is the more 
severe form of DM. DM caused by the expansion of CCTG repeat in the first intron of 
ZNF9 gene is called myotonic dystrophy type 2 (DM2) (Ranum et al. 1998; Liquori et al. 
2001). It is also called the proximal myotonic dystrophy (PROMM). This is a relatively 
mild form of DM (Machuca-Tzili, Brook, and Hilton-Jones 2005). DM1 and DM2 are 
thought to be caused by accumulation of toxic RNA (J. E. Lee and Cooper 2009; 
Osborne and Thornton 2006; Thornton 2014). DM symptoms include myotonia, 
cataracts, neurological disorders and heart conduction defects. 
 DM1 was first described more than hundred years ago (Machuca-Tzili, Brook, 
and Hilton-Jones 2005). It was the third example of a disease caused by repeat 
expansions in 1992 (Thornton 2014; Brook et al. 1992; Mahadevan et al. 1992; Y. H. Fu 
et al. 1992). The number of CTG repeat in general human population is variable. The 
number of repeats in healthy individuals lies between 5 and 37 (Thornton 2014). In DM1 
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patients the number of repeats exceeds 50 and can even be more than 3000 (Thornton 
2014). The number of repeats correlates with the degree of severity of the disease. It 
also negatively correlates with the age of onset, the larger of number of repeats being 
associated with an earlier age of onset (Redman JB et al. 1993; Temmerman et al. 
2004). DM1 can present in either congenital or adult onset form. This depends on the 
number of repeats in an individual.  
 DM2 was first described in 1994 as the myotonic dystrophy that lacked the CTG 
repeat expansion described two years earlier (Thornton, Griggs, and Moxley 1994). A 
number of DM patients were soon found to lack the CTG expansion (Ricker K et al. 
1995; Ricker et al. 1994; Meola et al. 1996; Udd et al. 1997). This form of the disease 
was initially called proximal myotonic myopathy because of the involvement of proximal 
muscles, in contrast to the distal muscles in the previously described form of DM (Udd 
et al. 1997; Moxley III 1996; Ricker et al. 1994). It was later renamed as DM2 to signify 
the form of DM that lacked CTG repeat expansion. DM2 is an adult onset disease. A 
congenital form of DM2 has not been identified. DM2 was subsequently found to have a 
CCTG tetranucleotide expansion in the first intron of Znf9 gene(Liquori et al. 2001).  
 The expression of RNA with the DM repeat expansions leads to the formation of 
RNA foci in the nucleus. It has been proposed that important RNA processing factors 
bind to the repeat containing RNA and are sequestered in these foci. This leads to the 
misregulation of RNA processing, including defects in splicing and polyadenylation. As 
such DM has been characterized as a RNA toxicity disease (Thornton 2014; Cho and 
Tapscott 2007; Turner and Hilton-Jones 2014; Machuca-Tzili, Brook, and Hilton-Jones 
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2005; J. E. Lee and Cooper 2009; Osborne and Thornton 2006; Douglas and Wood 
2011).  
There is a large body of literature describing the alterations in the RNA 
processing machinery (Osborne and Thornton 2006; Douglas and Wood 2011). 
However, the effect of the defect in RNA processing on the proteome is poorly 
understood. In this study, we used quantitative proteomics analysis to determine the 
changes in the proteomes of the skeletal muscles of DM patients.  
Materials and Methods 
Patient details: Muscular biopsies were kindly provided by Dr. Bjarne Udd from 
University of Helsinki, Finland. 
iTRAQ quantitation of the proteome: Protein extract was prepared by ultrasonicating 
the skeletal muscle tissue in lysis buffer (50% Trifluoroethanol 50 mM HEPES). The 
amountsl protein in the samples were determined using BCA assay. 10 µg of protein 
was aliquoted out, reduced by tris(2-carboxyethyl)phosphine, cysteine blocked by 
Methyl methanethiosulfonate, and digested with trypsin (1:50 :: trypsin:protein) 
overnight. The peptides were desalted using solid phase extraction with reverse phase 
microtrap coloum (Michrom Bioresources) as described in Link and La Baer. The 
peptides were resolublized in 7 ul 500 mM triethylammonium bucarbonate (TEAB). 85 ul 
of isopropyl alcohol was added to iTRAQ reagents. 12 µL of iTRAQ reagents were 
added to the samples, incubated with shaking for 2 hours, pooled, frozen, lyophilized, 
resolublized in buffer A (5% acetonitrile, 0.1 % formic acid in HPLC grade water) and 
stored at -80 0C. The iTRAQ labeled samples were analyzed by MudPIT essentially as 
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described with one change (Browne et al. 2013). The precursor ions were analyzed in 
the Orbitrap followed by 4 CID fragment ion scans in the ion trap to identify the peptides 
followed by 4 HCD fragment ion scan of the same precursors as in CID to get obtain the 
reporter ion intensities in the orbitrap.  
Mass spectrometry data processing and analysis: Mass spectrometry data 
processing was done as described in (Samir et al. 2015). RAW files generated by LC-
MS/MS experiments were searched using Sequest database search engine running 
under proteome Discoverer v1.4 (Thermo Scientific) to identify the peptides (Eng et al. 
2008; Eng, McCormack, and Yates 1994). Sequest searches were done against an 
ENSEMBL database of human protein sequences. Protein assembly and reporter ion 
quantitation and statistical analysis were done using ProteoIQ (Premier BioSoft). Log2 
transformed fold change against a common control prepared from lysates of wild type 
myoblasts (PromoCell) was used as the measure of abundance. Correlation plot was 
generated in R (R Core Team 2015). 
Differential expression and pathway analysis: One way ANOVA was used to identify 
differentially expressed proteins using in R using a modified version of a previously 
described script (Samir et al. 2015; R Core Team 2015). The modification allowed using 
data from control patients as covariates. Pathway analysis using the differentially 
expressed proteins was done using the GeneMANIA Cytoscape plugin (Montojo et al. 
2010; Mostafavi et al. 2008). Cytoscape was used to visualize the network diagrams 
(Shannon et al. 2003). Bar graphs were generated in MS Excel. 
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Results 
Proteomic analysis of myotonic dystrophy skeletal muscle biopsies. 
We analyzed the proteome of skeletal muscle biopsies from 5 control subjects, 7 
DM1 patients, and 6 DM2 patients. We used iTRAQ labeling followed by MudPIT 
analysis for the quantitation (Ross et al. 2004; Link et al. 1999). We quantitated 3575 
proteins across the three groups (fig. 20A). We analyzed the list of quantitated proteins 
using GeneMANIA Cytoscape plugin to identify the list of overrepresented pathways in 
the list (Montojo et al. 2010). GeneMANIA generated network had 801 nodes and 64138 
edges (fig.20B). A smaller number of nodes in the network compared to the input list of 
proteins represent the redundancies in the protein list due to the presence of multiple 
isoforms. The overrepresented pathways included a number of pathways expected to 
be involved in muscle physiology. The top 5 pathways enriched the list were contractile 
fiber part, muscle filament sliding, actin-myosin filament sliding, contractile fiber, and 
muscle system process (fig. 20C). In addition to muscle related pathways, energy 
production and translational control pathways were also enriched the list of quantitated 
proteins. This was expected based upon the cellular abundances of translational control 
proteins and metabolic enzymes.  
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Figure 20 – Quantitative proteomics analysis of skeletal muscles from DM patients 
A) Heatmap showing the expression ratioed against the common control. B) Network interactions 
generated using GeneMANIA. C) Top 6 enriched pathways in the list of proteins identified across all the 
experiments. CF1 is control female 1, CF1 is control female 2, CM1 is control male 1, CM2 is control male 
2, CM3 is control male 3, DM1F1 is DM1 patient female 1, DM1F2 is DM1 patient female 2, DM1F3 is 
DM1 patient female 3, DM1M1 is DM1 patient male 1, DM1M2 is DM1 patient male 2, DM1M3 is DM1 
patient male 3, DM1M4 is DM1 patient male 4, DM2F1 is DM2 patient female 1, DM2F2 is DM2 patient 
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female 2, DM2F3 is DM2 patient female 3, DM2F4 is DM2 patient female 4, DM2M1 is DM2 patient male 
1, DM2M2 is DM2 patient male 2. 
Closer analysis of the GeneMANIA generated network revealed that all but two 
nodes were part of a subnetwork spanning rest of the nodes. The two nodes were zinc 
finger 788 (ZNF788) and proline rich basic protein-1 (PROB1). They were not 
connected to any other node in the network. ZNF788 belongs to krueppel c2h2 type 
zinc finger protein family (The UniProt Consortium 2015). No disease mutation in 
ZNF788 has been reported (Peterson et al. 2010). PROB1 has been found to be 
mutated in human cancers (Wu et al. 2014). 
Protein downregulated in both DM1 and DM2 
Proteins products of three genes, RPL13A, P4HB, and MYH7B, were found to be 
downregulated in both DM1 and DM2 (Figure 21A-C). RPL13A is a ribosomal protein 
with diverse functions in translational control (The UniProt Consortium 2015). It has not 
been associated with a disease in DMDM database (Peterson et al. 2010). It has been 
found to be mutated in human cancers, which might be reflecting its polymorphism (Wu 
et al. 2014). RPL13A was found to have extraribosomal function in translational control 
of interferon regulated mRNAs. This led to the proposition of the depot hypothesis 
(Mazumder et al. 2003; Ray, Arif, and Fox 2007). According to ENSEMBL database 
(Ensembl release 82) RPL13A pre-mRNA contains 8 exons and 7 introns (Cunningham 
et al. 2015). A number of transcripts with retained introns have been reported. These 
transcripts are not translated into proteins (Cunningham et al. 2015). Since aberrant 
splicing is a common defect in DM1 and DM2, it provides a mechanism by which 
RPL13A protein levels might be downregulated in both DM1 and DM2.  
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GeneMANIA based pathway analysis to find pathways that might be affected by 
changes in RPL13A levels revealed translational control as the main pathway. Most of 
the proteins in the resulting network were ribosomal proteins (Fig. 21A). One of the 
members of the RPL13A network is Mago-Nashi Homolog (MAGOH), which is a 
member of exon junction complex (The UniProt Consortium 2015). MAGOH regulates 
neural stem cell division. A haploinsufficiency in Magoh leads to reduced brain size in 
mouse (Silver et al. 2010). 
 Second protein downregulated in both DM1 and DM2 is prolyl 4-hydroxylase, 
beta polypeptide (P4HB) (Fig. 21B). P4HB belongs to protein disulfide isomerase family 
of proteins (The UniProt Consortium 2015). P4HB has not been found to be associated 
with a human disease, but it has been found to be mutated in human cancers that might 
be reflecting its polymorphism (Peterson et al. 2010; Wu et al. 2014). P4HB pre-mRNA 
contains 11 exons and 10 introns. Similar to RPL13A, a number of transcripts with 
retained introns have been described. These transcripts are not translated into proteins 
suggesting a mechanism of downregulation dependent upon aberrant splicing 
(Cunningham et al. 2015). GeneMANIA analysis of a network generated from P4HB 
revealed association with metabolic enzymes (Fig. 21B). 
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Figure 21 – Network of interactions of the three genes downregulated in both DM1 and DM2 
Networks were generated using GeneMANIA Cytoscape plugin. The gene corresponding to the identified 
protein is colored green. Grey nodes were inferred from by GeneMANIA. A) Network of interactions of 
ribosomal protein RPL13A. B) Network of interactions of P4HB. C) Network of interactions of MYH7B. 
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The third and final protein downregulated in both DM1 and DM2 was Myosin heavy 
chain 7B (MYH7B) (Figure 21C). MYH7B has 9 transcripts that are generated by 
alternative splicing (Cunningham et al. 2015). The largest protein coding isoform has 43 
exons and 42 introns. The smallest protein coding isoform has 4 exons and 3 introns. 
There is a transcript with retained intron that does not code for a protein (Cunningham 
et al. 2015). MYh7B has been associated with left ventricular noncompaction disease 
(Cunningham et al. 2015). The large numbers of introns in MYH7B pre-mRNA makes it 
very susceptible to defects in splicing machinery. GeneMANIA analysis of a network 
generated from MYH7B revealed interactions with other myosins as well as other 
cytoskeletal components (Fig. 21C). 
Protein upregulated in both DM1 and DM2 
 Protein products of three genes were found to upregulated in both DM1 and DM2 
(Fig. 22A-C). The first gene is ATPase, Ca++ transporting, cardiac muscle, fast twitch 1 
(ATP2A1). ATP2A1 is an ATP dependent calcium ion transporter responsible for 
reuptake of Ca++ ions into the sarcoplasmic reticulum in striated muscles. A mutation in 
ATP2A1 has been found to be associated with Brody disease (Odermatt et al. 2000). 
Brody disease is a rare inherited myopathy characterized by delayed skeletal muscle 
relaxation and silent cramps (Voermans et al. 2012). This is similar to myotonia 
observed in DM, in which patients have difficulty relaxing their muscles. Brody disease 
is associated with a loss of Calcium uptake function of ATP2A1. The significance of an 
upregulation of ATP2A1 in both DM1 and DM2 is not immediately clear. GeneMANIA 
analysis of the network generated from ATP2A1 revealed its associations with a number 
of cytoskeleton components (Fig. 22A). 
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Figure 22 – Network of interactions of the three genes upregulated in both DM1 and DM2 
Networks were generated using GeneMANIA Cytoscape plugin. The gene corresponding to the identified 
protein is colored red. Grey nodes were inferred from by GeneMANIA. A) Network of interactions of 
ribosomal protein ATP2A1. B) Network of interactions of RAP1A. C) Network of interactions of RAP1B. 
The other two proteins upregulated are Ras-related protein Rap-1A (RAP1A) and 
Ras-related protein Rap-1b (RAP1B) (Fig. 22B-C). They are paralogous proteins with 
similar sequences. They have been reported because it was not possible to distinguish 
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between the two based upon the identified proteins. They are members of RAS 
oncogene family. RAP1A has 4 transcripts generated from alternative splicing, while 
RAP1B has 33 transcripts. Neither protein has been found to be associated with an 
inherited human disease (Peterson et al. 2010). GeneMANIA network generation and 
analysis using RAP1A and RAP1B individually revealed associations with signaling 
pathways as well as translation initiation factor. RAP1B was found to associate with 
translation initiation factor eIF5 as well ubiquitin. 
Proteins downregulated in DM1 
 GeneMANIA network generation and pathway analysis revealed muscle function 
related pathways to be overrepresented in the list of proteins downregulated only in 
DM1 (Fig. 23A-B). There are 56 downregulated gene products in the GeneMANIA 
network (Fig. 23A). The downregulated proteins included critical components of 
muscles including Titin (TTN), myosin light chains, and myosin heavy chain. It also 
included energy producing metabolic enzymes such as Phosphoglycerate kinase 1 
(PGK1) and Fructose-bisphosphate aldolase A (ALDOA). Both of the proteins have 
been associated with neuromuscular diseases (The UniProt Consortium 2015). Top 5 
misregulated pathways in the list of proteins downregulated in DM1 are muscle filament 
sliding, actin-myosin filament sliding, actin-mediated cell contraction, actin filament-
based movement, and muscle contraction (Fig. 23B).  
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Figure 23 – Pathway analysis of proteins downregulated in DM1 
Networks were generated using GeneMANIA Cytoscape plugin. The nodes corresponding to the 
identified proteins are colored green. Grey nodes were inferred from by GeneMANIA. A) The network 
interactions generated using GeneMANIA. B) Top 5 enriched pathways in the list. 
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Another protein downregulated in DM1 is Superoxide dismutase (SOD1). A 
number of mutations in SOD1 has been found to be associated with inherited familial 
amyotrophic lateral sclerosis (ALS) (Nakano et al. 1994; Rosen et al. 1993; Kostrzewa, 
Burck-Lehmann, and Müller 1994; P. M. Andersen et al. 2003). ALS shares many 
similarities with DM (Robberecht and Philips 2013). Misregulation of SOD1 is an 
interesting candidate event that could explain the similarities between ALS and DM. 
 Heat shock 70kDa protein 8 (HSPA8) is also downregulated in DM1. HSPA8 is a 
multifunctional protein involved in activation of transcription, protein quality control and 
bacterial lipopolysaccharide response in immune cells (Matsumura, Sakai, and Skach 
2013; Triantafilou, Triantafilou, and Dedrick 2001; Yahata et al. 2000). Although HSPA8 
has not been implicated in inherited human diseases, as part of PRP19-CDC5L 
complex it binds to all the core components of spliceosomes (Makarova et al. 2004). A 
downregulation of HSPA8 might contribute to the splicing anomalies observed in DM1. 
Proteins upregulated in DM1 
 The analysis of proteins upregulated in DM1 revealed protein products of 39 
genes (Fig. 24). The network generated in GeneMANIA contains the 39 query genes 
and 20 associated genes (Fig. 24A). Top five enriched pathways in the list are positive 
regulation of mitochondrial membrane permeability involved in apoptotic process, 
mitochondrial outer membrane permeabilization, protein insertion into mitochondrial 
membrane involved in apoptotic signaling pathway, regulation of mitochondrial outer 
membrane permeabilization involved in apoptotic signaling pathway, and regulation of 
protein insertion into mitochondrial membrane involved in apoptotic signaling pathway 
(Fig. 24B). 
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 One protein upregulated in DM1 is Elongation factor 1-alpha 2 (EEF1A2). 
EEF1A2 is a translation elongation factor belonging to TRAFAC class translation factor 
GTPase superfamily and EF-Tu/EF-1A subfamily. It contains one tr-type G (guanine 
nucleotide-binding) domain (The UniProt Consortium 2015). EEF1A2 has two 
transcripts generated from alternative splicing. Both of the transcripts code for a 463 
amino acid protein. One of the mRNAs is made 8 exons, 7 of which constitute the 
coding region while the other consists of 7 exons all of which are coding (Cunningham 
et al. 2015). EEF1A2 has been found to be associated with Epileptic encephalopathy, 
early infantile, 33 (Veeramah et al. 2013; de Ligt et al. 2012). EEF1A2 has also recently 
been found to be associated with Mental retardation, autosomal dominant 38 (Nakajima 
et al. 2015). Given the neurological symptoms of DM1, the aberrant function EEF1A2 in 
DM1 seems to be one of the contributing factors in DM1 (de León and Cisneros 2008). 
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Figure 24 – Pathway analysis of proteins upregulated in DM1 
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Networks were generated using GeneMANIA Cytoscape plugin. The nodes corresponding to the 
identified proteins are colored red. Grey nodes were inferred from by GeneMANIA. A) The network 
interactions generated using GeneMANIA. B) Top 5 enriched pathways in the list. 
Another translational control protein upregulated in DM1 is ribosomal protein 
S27a (RPS27A). RPS27A contains ubiquitin on its N-Terminus. It has 10 transcripts, 4 
of which are protein coding (Cunningham et al. 2015). The largest protein coding 
transcript consists of 6 exons, 5 which of which are coding exons. The smallest protein 
coding transcript consists of 5 exons with 4 coding exons. Six non-coding transcripts 
generated from RPS27A gene contain retained introns (Cunningham et al. 2015). 
RPS27A has not been found to associated with an inherited human disease (Peterson 
et al. 2010). RPS27A is one of the major contributors to the ubiquitin pool in the cells 
(Bianchi et al. 2015). It is also involved in regulation of p53 level through degradation of 
its regulator MDM2. Overexpression of RPS27A was shown to stabilize and increase 
the amount of p53 (Xiong et al. 2011). It has been shown that DM1 muscles undergo an 
increased rate of apoptosis (Loro et al. 2010). An increase in the amount of of RPS27A, 
which might lead to an increase in p53 and apoptosis, provides a putative mechanism 
for explaining this observation. 
Discussion 
A common theme in the proteins whose expression is altered in both DM1 and 
DM2 is the presence of alternative splicing in their mRNA maturation. This is in 
agreement with the previous studies that showed a central role for aberrant splicing in 
DM pathogenesis. In addition to supporting the previous studies, we have identified a 
number of candidate proteins pathways that are attractive targets for follow up studies.  
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Formation of cataracts is a common symptom in both DM1 and DM2. This was 
initially thought to be caused by a decrease in expression of SIX5 gene in DM1 (Klesert 
et al. 1997; Klesert et al. 2000; Sarkar et al. 2000). The decrease in SIX5 expression is 
attributed to the changes in the heterochromatin around the DMPK locus. Since ZNF9 
locus is not on the same chromosome, this suggested that the decrease in SIX5 protein 
may not be the common mechanism behind cataract formation. It was also noted that 
the type of cataracts observed in mouse deficient in Six5 and DM patients were different 
(Rhodes et al. 2012). To identify candidate causal agents, a microarray study was done 
on lens from DM patients (Rhodes et al. 2012). The study revealed differential 
expression of interferon responsive genes. These genes might be activated in response 
to double stranded RNA (dsRNA) in the cells (Rhodes et al. 2012). An important feature 
of immune response is the temporal regulation of gene expression so that the 
probability of a runaway immune response leading death of the host is reduced (R. 
Mukhopadhyay et al. 2009). 
A critical player in regulating the inflammatory response is the GAIT complex (R. 
Mukhopadhyay et al. 2009). GAIT complex is heterotetrameric complex consisting of 
IFN-γ-activated inhibitor of translation (GAIT) complex comprising glutamyl-prolyl tRNA 
synthetase (EPRS), NS1-associated protein 1 (NSAP1), RPL13A, and glyceraldehyde-
3-phosphate dehydrogenase (GAPDH). GAIT complex is maintained in an inactive state 
in which RPL13A is not present. RPL13A phosphorylation on the ribosome triggers its 
release from the ribosome. Its subsequent binding to the inactive GAIT complex 
activates it. The activated GAIT complex binds to the 3’UTR of target mRNAs and 
inhibits translation initiation (R. Mukhopadhyay et al. 2009). A decrease in RPL13A 
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protein levels can cause failure of activation of GAIT complex. This might lead to a 
decrease in the resolution of inflammation and can explain the observation of differential 
expression of immune responsive genes in DM eyes (Rhodes et al. 2012). 
A number of other candidate genes have been identified in this study that can 
contribute to the different symptoms observed, especially in DM1. Surprisingly, no DM2 
specific changes in the protein levels were observed. This could be because of the 
milder phenotype of DM2. Since we solely relied on the statistical significance obtained 
from our linear regression analysis, a technical reason could be the high variance in the 
proteomic expression patterns of DM2 patients. Nevertheless, this study provides an 
important resource and catalog of proteins differentially expressed in DM1 and DM2. 
Studies in mouse models of DM2 had suggested a key requirement for ZNF9 
protein, whose loss was able to recapitulate some of the symptoms of DM2 (W. Chen et 
al. 2007). This suggested that loss of function of a protein was at least contributing to 
DM pathogenesis in DM2. It became imperative to find the molecular function of ZNF9 
protein. Previous studies in the Link lab had suggested a role for translational control in 
DM2 pathogenesis due to the molecular function of ZNF9 protein. ZNF9 was found to 
be involved in IRES mediated translation in yeast as well as cell culture models of DM1 
(Gerbasi and Link 2007; Sammons et al. 2010). Another common theme in this study 
was the misregulation of many translational control proteins. It provides further evidence 
for the critical role of translational control in health and disease. 
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Chapter V 
Conclusions and Future Directions 
In my graduate research, I studied three problems of the regulation of biochemical state 
and the information repertoire of cells and tissues. The first problem involved studying 
the regulation of biochemical states by the information from outside the cellular 
boundary. I built a conceptual basis for interpreting complex cellular responses to 
multiple concurrent environmental stimuli. The second problem involved testing the 
ribosome filter hypothesis. A ribosome filter is a ribosome mediated regulatory element 
that controls the amount of information flow from specific mRNA transcripts to proteins. 
The third and final problem was to investigate the proteomic changes in the skeletal 
muscles of myotonic dystrophy patients. These proteomic changes might have been 
caused by the disruption of information flow due to microsatellite repeat expansions in 
the genomes of the patients. 
Cellular responses to environmental stimuli 
The complement of molecules contained in a cell, including the cell surface, 
constitutes its biochemical state. The biochemical state is a reservoir of information. The 
genetic material of an organism, its DNA or RNA, contains the template information 
which is used to synthesize all of the necessary molecules, or in some cases the 
molecules that can make or modify those molecules. The flow of information from the 
genetic material to the functional molecules, for example RNAs or Proteins, is known as 
the central dogma (Crick 1970). An organism uses the information flow to respond to 
and modify its environment. This flow of information, however, is not linear. The DNA 
bases can be covalently modified that affects the information flow through transcription 
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(Suzuki and Bird 2008; Robertson 2005; T. Phillips 2008). Similarly, RNAs have been 
found to be extensively edited or modified, which also modifies their information content 
(Nishikura 2010). In most of these processes, the class of molecules responsible for the 
function, the molecular actuators, are the proteins. Although the backbone of the protein 
can be synthesized solely based upon the information content in the genetic material, 
with the notable exception of those synthesized from edited mRNA templates, they 
themselves can be covalently modified after synthesis. The covalent modifications can 
have many functions that include altering the biochemical activity of the proteins, 
modulating sub-cellular localization or binding to cofactors, and targeting or protecting 
for degradation (Wells, Whelan, and Hart 2003; P. Anderson and Kedersha 2009; Wold 
1981; Lodish 1981; Nussinov et al. 2012; Vucic, Dixit, and Wertz 2011; Beltrao et al. 
2013; Terman and Kashina 2013).  This adds another layer of information content. 
There are two fold consequences of this added layer: (1) it allows the living beings to 
store more information (increase in information repertoire) that it can use to respond to 
a wider range of environments, and (2) the prior biochemical state, including its 
complement of proteins and their covalent modifications, determines the exact cellular 
response. 
 The information repertoire of the cells, therefore, is dependent upon two factors; 
(1) the information in the genetic material, and (2) the information in the environmental 
stimuli, including the prior stimuli they had been exposed to. Extrapolating this logic, 
since genes and stimuli are just packets of information that cells use for their continued 
survival, as an abstraction they can be thought to be the same. There is a very 
 130 
 
important consequence of this assumption, viz. the tools used for studying genes can 
be applied for stimuli. 
 The information flow from genes has been a well-studied problem. Consequently, 
there is a large body of work and a well-defined conceptual basis associated with it. The 
conceptual basis for studying information flow and integration of information from 
multiple genes is called gene interactions. It provided, in many cases, an easy 
interpretation of observed changes in the characteristics or traits upon alterations in 
genes. It has also been used to decipher the order in biochemical and signaling 
pathways making it a very valuable tool for research (St Johnston 2002). With the 
abstraction that stimuli are analogous to genes, most of these concepts and tools can 
become available for studying the effects of multiple concurrent stimuli.  
 I used one of the abstractions, the dominance in gene interactions, as a tool to 
identify proteins and transcripts that are important for responding to specific stimulus in 
S. cerevisiae. The assumption here was that if a protein or transcript contains the 
information important for responding to a stimulus, the effect of the stimulus would be 
dominant over the effects of an unrelated stimulus. There is a caveat associated with 
this approach that makes using absolute dominance fraught with false negative results. 
If a biomolecule contains information for responding to multiple stimuli among the set 
under investigation, dominance will not observed. This would lead to a false negative 
result. To address this caveat and further refine the idea follow up studies are needed. 
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Follow up studies about environmental interactions and epistasis 
 The follow up studies on environmental interactions and epistasis can be 
classified into two categories – (1) showing the general applicability of the ideas, and (2) 
understanding the mechanistic basis behind the interactions. 
 The validity of the concepts of environmental interactions and epistasis has been 
shown only in S. cerevisiae with the transcriptomic and proteomic changes (Samir et al. 
2015). Paucity of published datasets in other organisms makes it difficult to test the 
general validity of the concept. There is a published dataset in which liquid cultures of A. 
thaliana cells were used to study the effects of carbon dioxide concentrations and high 
salinity on the transcriptome as well as the metabolome (Kanani, Dutta, and Klapa 
2010; Dutta et al. 2009). This dataset is ready resource to test the validity of the 
conceptual basis in plants. The post-translational modifications data in the study of high 
osmolarity or pheromone signaling provides a resource for testing the hypothesis with a 
different cellular response, albeit still in S. cerevisiae (Vaga et al. 2014). 
 HeLa cells could be used to test the hypothesis in mammalian systems. The 
stimuli used could be increasing concentrations of two inhibitors that target different 
signaling pathways. Rapamycin can be used to inhibit the mTOR pathway while one of 
the “inhibitors of Wnt response” compounds (Law 2005; Baozhi Chen et al. 2009). 
Transcriptomic responses can be measured by RNA-Seq and the proteomic responses 
can be measured by iTRAQ labeling liquid chromatography tandem mass spectrometry 
(Ross et al. 2004; Cloonan et al. 2008; Lister et al. 2008; Nagalakshmi et al. 2008; B. T. 
Wilhelm et al. 2008; Mortazavi et al. 2008). Phosphoproteomics analysis can be used to 
assay the changes in phosphorylation states of the target proteins (Winter et al. 2012). 
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Mouse models of T-cell and B-cell activation can be used to test the validity in 
mammalian systems in vivo. An ovalbumin specific transgenic mouse, OT-1 can be 
used as the model system. This strain of mice contains T-cell receptor that is specific to 
a peptide antigen generated from ovalbumin (Hogquist et al. 1994; Clarke et al. 2000). 
The stimuli used can be different concentrations of the antigenic peptide and the 
adjuvants. The transcriptomic and proteomic responses can be assayed in peripheral 
blood mononuclear cells (PBMC) and polymorphonuclear cells (PMN). Metabolomic 
changes can be assayed in blood plasma. An important feature of this study design is 
the use of different concentrations of the stimuli. A multiple linear regression model built 
with the different concentrations can help identify the molecules that are important for 
responding to multiple stimuli if their response is dose dependent. 
 The second aspect, to identify a mechanistic basis for the observed phenomenon 
can be done in S. cerevisiae using the same stimuli as before with quantitative 
proteomics analysis. In this study, a time course experiment would be needed. The 
order of application of the second stimuli would need to be changed. This experiment 
design would allow assay of kinetics of modulation of the proteome. The biomolecular 
complexes, or their components, that are differentially regulated in the kinetics 
experiments can be the candidates, with an assumption that they are involved in the 
modulation information flow, for pursuing more in depth biochemical and genetic 
analyses. 
Regulation of proteome by the ribosome filter 
 In this study, I used two complementary techniques, quantitative mass 
spectrometry and cryo-EM (in collaboration with the Joachim Frank lab), to test the 
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ribosome filter hypothesis by measuring changes in the protein composition of the 
ribosomes. The ribosome filter provides a mechanism for the ribosomes to regulate 
information flow through translational control. It can act through the use of specific 
paralogs for translating specific mRNAs more efficiently.  
I identified 11 ribosomal proteins whose abundances in the purified ribosomes 
were changing. The list included a paralog pair, Rpl8a and Rpl8b. Polysome profiling 
with the null mutants of either Rpl8a or Rpl8b suggested that their functions are not 
redundant. I identified 80S ribosomes with substoichiometric protein compositions using 
cryo-EM. A time course experiment after shifting cells from a glucose containing media 
to a glycerol containing media followed by ribosome purifications cryo-EM analysis 
showed that the proportions of the substoichiometric ribosomes were changing. This 
suggested the cells dynamically regulate their ribosome composition. 
In conclusion, I have used two techniques to assay the changing composition of 
ribosomes. These changes support the ribosome filter hypothesis. Follow up 
experiments are needed to identify the transcripts affected by Rpl8a/b mediated 
ribosome filter as well the underlying mechanism. 
Follow up studies on ribosome mediated translational control 
 I have identified a candidate paralog pair, Rpl8a and Rpl8b, which might have 
specific functions in translation. They might be required for translation of specific 
transcripts. However, the identity of the transcripts is not known. Ribosome footprint 
profiling after RNAse treatment can be used to identify such transcripts. Once the 
transcripts have been identified, two complementary approaches can be used to 
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decipher the mechanism through which RPL8A or RPL8B helps translate specific 
transcripts. In the first approach, a bioinformatics search can be performed to find 
sequence motifs overrepresented in transcripts that need a specific paralog. Reporter 
assays can be done to check the effects of the sequence motifs on translation. In the 
second approach, in vitro translation reactions using the ribosomes from the null 
mutants can be used to directly assay the rate of translations of the identified 
transcripts. The transcripts will need to be in vitro transcribed to ensure quality control 
across experiments.  
 After testing the ribosome filter hypothesis in yeast, it could be tested in 
mammalian cell culture system using a similar approach. In this case, HeLa cells can be 
used as the model system because they are one of the most well characterized 
mammalian cell culture systems. 
 Another question that arises from this study deals with the exact mechanism(s) of 
change in the composition. There can be three models that explain the changes in the 
composition. In the first model, there are free floating ribosomal protein paralogs in the 
cytoplasm or nucleus. Upon specific signaling cues, the paralog on the ribosome is 
exchanged for the free floating one. The advantage of this model for the cell is that the 
kinetics of changing composition will be the fastest. However, the cells would need to 
synthesize proteins that they do not need at any given time. This will mean expenditure 
of energy to keep the system primed. Since translation is the most energetically costly 
process in the cells, and translation of ribosomal proteins constitutes a very large chunk 
of the total expenditure, the energetic cost for the cell will be very high. In the second 
model, new ribosomes are synthesized with specific paralogs in response to signaling 
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cues. In this model, there is less expenditure of energy as cells synthesize only the 
ribosomal proteins and rRNAs that they need at any given time. However, a 
disadvantage of this model for the cell is that the response time might be very high. This 
is because the biogenesis of ribosomes requires multiple steps. In the third model, the 
cells degrade the ribosomes that contain the paralogs that they do not need. The short 
term energy cost of this model is the least because it does not require synthesis of new 
ribosomes. However, the long-term energy cost of this model might be the highest 
because it does not involve synthesis of ribosomes only with the paralog that is needed. 
This means the cells will have to continuously spend energy on making ribosomes that 
it does not need and then degrade it. To decipher the exact mechanism, labeling with 
stable isotopes followed by mass spectrometry quantitation can be used.  
Regulation of proteome by RNA repeat expression in myotonic dystrophy 
RNA repeat expansion disrupts the information flow by sequestering important 
RNA binding factors that regulate the transfer and modification of information from 
genome to proteins. I have identified several candidate proteins that might have roles in 
DM pathogenesis. This included RPL13A, P4HB, and MYH7B. This study is a starting 
point for further studies with these candidate proteins to dissect the mechanism of 
disruption in information repertoire that leads to DM. 
Follow up studies about the proteomic changes in myotonic dystrophy 
 A number of interesting candidate proteins were identified that might play roles in 
DM pathogenesis. Since I am interested in translational control, especially the 
regulation by ribosomes, I think RPL13A is a very interesting candidate. A previous 
transcriptomic study had identified misregulation of inflammatory response genes in eye 
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lenses of DM patients. Since RPL13A protein has been shown to regulate inflammation 
in a temporal manner, it might be playing a role. Inflammation inside the eye has been 
found to be associated with cataract formation (Hodge, Whitcher, and Satariano 1994; 
Durrani et al. 2004). Since RPL13A inhibits translation of proinflammatory proteins as 
part of GAIT complex, its loss of function can cause persistent inflammation. This could 
explain the observation of cataracts in DM patients. The function of RPL13A can be 
studied in mouse models. 
 Since ZNF9 has been found to be involved in IRES mediated translation, it would 
be informative to find its in vivo targets. RNA-pulldown experiments followed by RNA-
Seq can be used to identify its targets. An attractive alternative is the PAR-CLIP for 
identification of RNA binding sites for candidate RNA binding proteins on the transcripts. 
An unrelated RNA binding protein, such as PABP can be used as a control in this 
experiment. Once the targets have been identified, their regulation in DM2 patients can 
be studied. Yeast, cell culture and mouse models can be used to study the effect of 
their loss of function. X-Ray crystallography can be used to determine the structural 
basis for Znf9 binding to mRNAs. 
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Appendix A – Table 1: Proteins Quantitated in Environmental 
Interactions Study 
https://drive.google.com/open?id=0BxmfH2AgA_HkQ2NnTTZ5eGZQa3M 
 
Appendix B – Table 2: GeneMANIA pathway analysis output 
for HT stimulus 
https://drive.google.com/open?id=0BxmfH2AgA_HkRTZNZGROeTE1Z1k 
 
Appendix C – Table 3: GeneMANIA pathway analysis output 
for G stimulus 
https://drive.google.com/open?id=0BxmfH2AgA_HkQ3h3WFFVcF9vZ2c 
 
Appendix D – Table 4: GeneMANIA pathway analysis output 
for HT+G stimulus 
https://drive.google.com/open?id=0BxmfH2AgA_HkbzFZMmRSRGJEYmc 
 
Appendix E – Table 5: GeneMANIA pathway analysis output 
for HT stimulus dominance 
https://drive.google.com/open?id=0BxmfH2AgA_Hkd2VEd0tkdHUtT28 
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Appendix F – Table 6: GeneMANIA pathway analysis output 
for G stimulus dominance 
https://drive.google.com/open?id=0BxmfH2AgA_HkQnE3M1ZwalpwT0E 
 
Appendix G – Table 7: GeneMANIA pathway analysis output 
for non-specific environmental response in protein 
expression 
https://drive.google.com/open?id=0BxmfH2AgA_HkcGc4bXhSOVF3V2c 
 
Appendix H - Table 8: GeneMANIA pathway analysis output 
for discordance in protein expression 
https://drive.google.com/open?id=0BxmfH2AgA_HkVFdiMW4xbGdaQzA 
 
Appendix I – Table 9: GeneMANIA pathway analysis output 
for suppression in protein expression 
https://drive.google.com/open?id=0BxmfH2AgA_HkeHJ4bWJvTzBlSEE 
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Appendix J – Table 10: GeneMANIA pathway analysis output 
for environmental epistasis in protein expression 
https://drive.google.com/open?id=0BxmfH2AgA_HkRTI2aWdZNUsyWDA 
 
Appendix K – Table 11: GeneMANIA pathway analysis output 
for no environmental epistasis in protein expression 
https://drive.google.com/open?id=0BxmfH2AgA_HkOEhOUTZiUGpRaW8 
 
Appendix L – Table 12: Complete data matrix of transcripts 
https://drive.google.com/open?id=0BxmfH2AgA_HkMTF5dzdwM1NLUm8 
 
Appendix M – Table 13: GeneMANIA pathway analysis output 
for environmental epistasis in transcript expression 
https://drive.google.com/open?id=0BxmfH2AgA_HkaGJiUXNLT0VjN2c 
 
Appendix N – Table 14: GeneMANIA pathway analysis output 
for dominance of NS 
https://drive.google.com/open?id=0BxmfH2AgA_Hkbzg0Q1lMYy1QVms 
 
 140 
 
Appendix O – Table 15: GeneMANIA pathway analysis output 
for dominance of AN 
https://drive.google.com/open?id=0BxmfH2AgA_HkUWdSbm5KclF5YWM 
 
Appendix P – Table 16: Doubling times under the 8 growth 
conditions 
https://drive.google.com/open?id=0BxmfH2AgA_HkbkdCVGp2WWJQMlk 
 
Appendix Q – R source codes for the analysis in 
environmental interactions analysis 
https://drive.google.com/open?id=0BxmfH2AgA_Hkdmp1ZG1STllYZkU 
 
https://drive.google.com/open?id=0BxmfH2AgA_HkZlp0OGNJTU16N0k 
 
https://drive.google.com/open?id=0BxmfH2AgA_HkMUMySWxOWmdNSXc 
 
https://drive.google.com/open?id=0BxmfH2AgA_HkMHozNjZ4NDA5OUU 
 
Appendix R – Python source code for GoZilla 
https://drive.google.com/open?id=0BxmfH2AgA_HkMlpiNTBQSUVZMkU 
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https://drive.google.com/open?id=0BxmfH2AgA_HkOTRGSVdsOWM0LVU 
 
https://drive.google.com/open?id=0BxmfH2AgA_HkZ1h4bkxMellCUTg 
 
https://drive.google.com/open?id=0BxmfH2AgA_HkemJCX2puNmYtSW8 
 
Appendix S – Python source code for CompZilla 
https://drive.google.com/open?id=0BxmfH2AgA_HkVnF2WkVKdy1PWUU 
 
https://drive.google.com/open?id=0BxmfH2AgA_HkanRTLWdDeEUyXzA 
 
https://drive.google.com/open?id=0BxmfH2AgA_HkZUZ6SDM2LWxwWmM 
 
Appendix T – Table 17: Purified ribosomes quantitative 
proteomics dataset. 
https://drive.google.com/open?id=0BxmfH2AgA_HkOHZacmI0WFcwcFU 
 
Appendix U – Table 18: Myotonic dystrophy quantitative 
proteomics datasets. 
https://drive.google.com/open?id=0BxmfH2AgA_HkRUwwci05U0FFaGs 
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Appendix W – Manuscript – 2: ℓ2 multiple kernel fuzzy SVM-
based data fusion for improving peptide identification 
 166 
 
 
 167 
 
 
 168 
 
 
 169 
 
 
 170 
 
 
 171 
 
 
 172 
 
 
 173 
 
Appendix X – Manuscript – 3: A Cell-Based Systems Biology 
Assessment of Human Blood to Monitor Immune Responses 
after Influenza Vaccination 
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Appendix Y – Manuscript – 4: Sculpting MHC class II-
restricted self and non-self peptidome by the class I Ag-
processing machinery and its impact on Th-cell responses 
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